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A BSTR A C T
The present work provides insights into several aspects of the regulated secretion in 
pancreatic P cells. We demonstrated a partial intracellular dissociation of two secretory 
granule (SG) markers, insulin (Ins) and chromogranin B (CgB), implicating distinct SG 
populations. In addition, we observed for the first time a redistribution of CgB, shifting 
from the SG core to the halo upon secretagogues application. We also found that upon 
ionomycin stimulation, CgB was preferentially released, possibly reflecting a higher 
sensitivity to Ca2+. These findings suggest a differential regulation of Ins and CgB at 
multiple levels.
Furthermore, we observed heterogeneous Ins and CgB expression levels in the rat 
insulinoma Rin-5 AH cell line. Among the sub-clones isolated therefrom, two displayed 
interesting features. The D2 sub-clone, showing nearly undetectable CgB levels and a 
lower Ins release compared to parental cells, suggested that CgB expression or secretion 
might affect Ins release. The Q2 sub-clone displayed high CgB content, accumulation of 
Ins and CgB in the Golgi complex and a poor secretion of both proteins; in addition, it 
showed a proportion of constitutively released Ins, suggesting a partial impairment of 
the secretory pathway. Q2 cells also displayed some features suggestive o f oxidative 
stress, i.e. impaired ATP production upon stimulation of Ins secretion and altered 
mitochondrial morphology and functionality. Such features were also observed in 
patients with type 2 diabetes (T2D), thus we propose the Q2 sub-clone as a model of 
T2D.
Next, we assessed whether a cell model bearing oxidative stress is more susceptible to 
endoplasmic reticulum (ER) stress. We induced a sub-lethal ER stress in Q2 cells and 
compared them to INS1-E. Our results showed a higher sensitivity of Q2 cells to 
activation of apoptosis. Further studies of this sub-clone might shed light on the still 
unclear correlation between oxidative and ER stress in diabetes.
X
IN TR O D U C TIO N
The study of the molecular mechanisms of regulated secretion in pancreatic (3 cells has 
provided valuable insights into the pathology of diabetes mellitus. Insulin (Ins) is 
secreted by a regulated pathway that is widely used in neuronal and neuroendocrine 
cells. This ability to store secretory products (i.e. neurotransmitters and hormones) in 
membrane-bound organelles (secretoiy granules, SGs) and to release them upon 
appropriate stimulation is termed neurosecretion competence J.
Ins is the main secretory product of pancreatic p cells, although other secretory products 
are co-stored in the SGs and co-released along with it. Any condition affecting secretory 
granules biogenesis, maturation and exocytosis may lead to an impairment of p cell 
function as seen in type 2 diabetes. In the last few years diabetes and p cell dysfunction 
have been associated with oxidative stress, i.e. a severe imbalance of the intracellular 
redox equilibrium. There is also a correlation between type 2 diabetes and a massive 
perturbation of the endoplasmic reticulum (ER) homeostasis, referred to as ER stress. 
The causes, the targets and the interrelations of oxidative and ER stress are only 
partially known, however their impact on p cell function is dramatic. They can affect 
multiple steps, including Ins synthesis, processing and correct folding, the signal 
transduction pathways implicated in the stimulus-secretion coupling, and late exocytotic 
events.
The major objectives of the work described in this thesis were to understand better the 
rules regulating the storage and secretion of Ins along with other secretory granule cargo
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molecules in (3 cell models and to investigate the role of oxidative and ER stress on 
neurosecretion competence using p-cells as a model system. We used Rin-5 AH p-cell 
lines that differed in their secretory response to glucose.
The following sections provide an overview of the secretory pathway and the 
mechanisms of exocytosis in endocrine cells, focusing on the pathways followed by Ins 
and chromogranin B from granule biogenesis to secretion. Insights will be provided on 
the complexity of Ins granule regulation and secretion. Next, the possible causes and 
effects of oxidative stress will be presented, with regard to their correlation with 
pancreatic p cell function. Finally, a brief introduction to the ER stress response and its 
implications in diabetes will be provided.
1. Mechanisms o f neurosecretion in endocrine cells
1.1 The secretory pathway
Nascent polypeptide chains are translocated from the ER membrane-bound ribosomes 
into the ER lumen, where the complete proteins are properly folded and, depending on 
the signal sequence contained, either retained in the ER or targeted to other 
compartments. Proteins destined for secretion progress and mature along the so-called 
secretory pathway, which is composed of different intracellular compartments (ER; 
Golgi complex, GC; trans-Golgi network, TGN). They are then sorted into secretory 
vesicles and targeted to their final location. Differently from peptides, low-molecular 
weight molecules, typically neurotransmitters, are not synthesised in the ER but in the 
cytoplasm, and are taken up by transporters into secretory vesicles leaving the TGN 2.
2
3This mechanism allows for a rapid, local recycling and refilling of secretory vesicles . 
Secretory proteins are finally discharged by the secretory vesicles by exocytosis, i.e. the 
process by which SGs fuse with the plasma membrane and their soluble content is 
released extracellularly, whereas the luminal membrane-bound proteins are exposed on 
the cell surface. In eukaryotic cells, exocytosis can take place either at a constant rate 
(constitutive secretion) or in a regulated manner (regulated secretion).
Trafficking from ER to GC - Transport from one compartment to another through the 
secretory pathway is mediated by carrier vesicles that collect the ‘cargo’ proteins in 
buds arising from the membrane of the donor compartment and deliver them to the 
target compartment by fusing with its membrane 4. After discharging their content, the 
transport vesicles return to the donor compartment and are recycled for a new cycle of 
transport5. Adaptor proteins on the cytoplasmic side of the vesicle membrane allow the 
appropriate cargoes to enter the forming vesicle 6 in a process called ‘sorting’. Vesicles 
budding from the ER and moving to the GC are equipped with a specific ‘COPII’ coat7, 
whereas vesicles moving into the retrograde direction from the GC to the ER have a 
‘COPI’ co a t8. As they progress through the cis, medial and trans cistemae of the GC, 
proteins undergo modifications such as oligosaccharide remodelling, proteolytic 
cleavage, phosphorylation, or sulfation. There are two possible mechanisms of protein 
transport through the GC 9’ 10. In the ‘anterograde vesicle’ hypothesis the cistemae are 
stable structures and transport vesicles move from stack to stack by anterograde 
transport, followed by COPI-coated vesicles-mediated recycling. According to the 
‘cisternal maturation’ hypothesis, cis-Golgi cistemae move and mature through the GC 
becoming progressively medial- and trans-Golgi cistemae. The modifying enzymes are 
continuously delivered, sorted and retrogradally transported by COPI-coated vesicles. 
Both models may be valid for different proteins n ’12.
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The post-Golgi compartment - After progression and maturation through the GC, 
proteins are transported to a collection of cistemae, tubules and vesicles, known as the 
TGN, which represents the major sorting station of the secretory pathway 13. From this 
compartment proteins are sorted, packaged into vesicles and targeted to different 
organelles: lysosomes and endosomes (through clathrin-coated vesicles), plasma 
membrane (through constitutive secretory vesicles or, according to recent findings, 
tubular structures that move along microtubules 14' 16) and SGs destined for regulated 
secretion.
After exocytosis, membranes and proteins are retrieved by endocytosis in clathrin- 
coated vesicles called endosomes, which move retrogradally to be recycled.
KEY:
clathrin
X )C O P I  
P  COPII
late en d o so m e
( 9 ° )  e n d o so m e
cisternae
/ plasma  
secretory mem brane  
vesicle
Golgi apparatus
Fig. 1 - Schematic model of the secretory pathway. See text for details. Molecular 
Biology of the Cell, 4th Edition.
Molecular mechanisms o f vesicle fusion - Transport vesicles and target membranes are 
provided with a molecular machinery aimed at recognising each other: the v- (vesicle)
4
and t- (target) SNARE (soluble N-ethylmaleimide [NEM]-sensitive factor attachment 
protein receptors) proteins. The SNAREs involved in intracellular and exocytotic 
trafficking, both constitutive and regulated, are homologs 17’ 18. The SNARE family is 
characterised by a ‘SNARE m otif, i.e. a 60 amino acid sequence that can form 
supercoiled structures. The interaction between the SNARE motifs of v- and t-SNAREs 
leads to the formation of a complex where the vesicles are ‘docked’ to the target 
membrane 19. Once the SNARE complex has been assembled, the vesicle membrane 
lipids fuse with the target membrane. Following membrane fusion, the SNARE complex 
is disassembled by factors, such as the ATPase NSF (NEM sensitive factor) 19 and a-, p- 
, y-SNAP (soluble NSF attachment proteins)20, and its components are recycled.
COMPARTMENT A
t-SNARE
cargo a v_sNAREs DOCKING 
cargo b /
FUSION
t-SNARE
COMPARTMENT B
Fig. 2 -  Model of vesicles docking and fusion with the target membrane. See text for 
details. Molecular Biology of the Cell, 4th Edition.
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1.2 Granule biogenesis
Immature vesicles budding, or just budded, from the TGN contain diffuse aggregates of 
secreted proteins. Constitutive and regulated secretion differ in that constitutive vesicles 
are continuously released after protein synthesis, whereas regulated granules are stored 
and released upon appropriate stimuli 21. The mechanism underlying protein sorting to 
one of the two pathways is still poorly defined; it is generally envisaged that sorting into 
the regulated pathway is controlled by selective protein aggregation (also referred to as 
condensation) 22, 23. There are two classical models, not mutually exclusive, for 
regulated granule formation: sorting for entry and sorting by retention. According to the 
first, proteins are sorted to regulated SGs by specific interactions with membrane 
receptors and by binding proteins that form insoluble aggregates in the regulated 
granules 24. These aggregates prevent proteins from entering constitutive vesicles, which 
represent a default pathway. In the latter model, a set of different proteins are thought to 
enter the forming vesicle; regulated secretory proteins (RSPs) are retained passively on 
the basis of their inter-molecular interactions and structure, yet other proteins' are 
actively removed during granule maturation 23. Intra-granular conditions, such as low 
pH and high Ca2+ concentrations, together with protein aggregation, promote retention 
of RSPs in the regulated SGs. Such a mechanism is believed to drive granule biogenesis 
in pancreatic p cells, where the presence of ions, such as zinc, further favours Ins 
condensation 25. It has been suggested that the sorting mechanism (for entry or by 
retention) might depend on the aggregation tendency of the protein and on the relative 
rate of protein synthesis and vesicle formation 26.
Regulated vesicles from mammalian secretory cells contain proteins, such as 
chromogranin A (CgA), chromogranin B (CgB), secretogranin II (Sgll), 
carboxypeptidase E (CPE) and several glycoproteins, capable of forming aggregates in
6
the ionic milieu of the TGN 27,28. For this reason, the aforementioned proteins may act 
as ‘helper’ proteins that favour RSPs condensation 24,29. This process could be the basis 
for sorting into regulated vesicles. CgA, CgB and CPE 30 33 may also act as ‘sorting 
receptors’, because of an N-terminal disulfide loop structure that might interact with 
soluble proteins and sort them into SGs. Furthermore, it was suggested that a small 
fraction of proteins such as CgB 34, proconvertase 2 (PC2)35, and C PE 36, might bind to 
the granule membrane through lipid microdomains (rafts)3?.
Another mechanism in the sorting of RSPs into regulated granules may be dependent on 
their processing by proconvertases (PCs), since the RSPs aggregates are more 
efficiently retained in the secretory pathway after processing 38, 39.
In summary, according to the prevailing hypotheses, secretory proteins that do not 
associate with helper proteins, and/or cannot form aggregates, are not retained in the 
regulated SG and would be sorted into constitutive transport vesicles. However, 
constitutive secretion is not just a default pathway; indeed,the targeting of its vesicles is 
regulated, as exemplified by the constitutive protein trafficking to the apical or 
basolateral membrane in epithelial cells 40’41, and to the axonal or the somato-dendritic 
region in neurons 42.
The regulated vesicles that exit the TGN are called immature secretory granules (ISGs), 
and are the first compartment of the regulated secretory pathway to acquire competence 
for stimulated release 43’44. During maturation, ISGs of some cell types may undergo 
homotypic fiision and removal of missorted material 43, modifying enzymes 45 and the 
‘immature’ SNARE machinery 38’46 through clathrin-coated vesicles (‘sorting by exit’ 
47) that are conveyed to the endosomal compartment.
Ins granule biogenesis - Ins is synthesised as a pre-prohormone (pre-proinsulin) 
containing an N-terminal signal sequence for ER targeting and a single polypeptide
7
chain contained amino acid sequences corresponding to the A and B chains of Ins and 
C-peptide. While progressing through the ER after cleavage of the signal sequence, 
proinsulin (proins) undergoes post-translational modifications consisting of inter- and 
intra-molecular disulfide bonds formation (within the A chain and between the A and B 
chain). Further along the secretory pathway, commencing within the ISGs 48, proins is 
processed into mature Ins upon cleavage at the B chain/C-peptide and C-peptide/A 
chain junctions by PC 1/3 and PC2 49,50 and by CPE/CPH 51. Proins is not able to 
aggregate beyond hexamerisation 25, 52, however it can enter forming granules along 
with other soluble proteins 53. After processing Ins can form multimeric, highly 
condensed structures (crystals)54’55, the formation of which is favoured by the presence 
of Zn2+. The Zn2+-Ins crystals are efficiently retained in the secretory granules. 
Condensation has been proposed to prevent Ins from escaping from maturing granules 
into budding constitutive-like vesicles 39,45, 56. The constitutive-like secretory pathway 
or post-granular secretory pathway 57? 58 has been proposed as a preferential route for a 
fraction of newly synthesised C-peptide, Ins and proins, that is removed from maturing 
granules 44’ 51. Constitutive-like vesicles are conveyed to the endosomal system and 
secreted 59. Therefore, this putative pathway might represent an alternative removal 
mechanism 60, that leads to refinement of granule composition during maturation.
The complexity o f secretory granules - Endocrine and neuroendocrine cells can store in 
secretory granules a mixture of hormones, peptides, amino acids, amines and
* A1 f f )nucleotides ’ . It has been generally postulated that when co-packaged in the same 
SGs 63, 64, peptides are also co-released 65, 66, while distinct SGs can be independently
rn
regulated . In pancreatic p cells, granules store other secretory proteins beside Ins, 
including some members of the granins family 68,69, IAPP (islet amyloid polypeptide), 
CART (cocaine- and amphetamine-regulated transcript) and PANDER (pancreatic-
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derived factor) 70"72. Contradicting the idea that co-packaged peptides are co-released, 
some proteins, such as C-peptide and nucleotides in p cells 54,73,74, that are not tightly 
associated with the granule core but are rather distributed in the clear halo, can be ready 
releasable as compared to proteins in the core. This is also the case for neurotransmitters
• 7 cm PC 12 cells . To make the picture more complex, the differential sorting of peptides 
into distinct subpopulations o f SGs has been reported in different cellular systems 76'79. 
Well documented examples for such intracellular sorting are the three peptides derived 
from the processing of the egg lying hormone precursor of Aplysia, which are stored 
into three different types of SGs 77’ 80, and the two hormones of neurohypophysial 
neurons, galanin and vasopressin, which are stored both separately in two distinct SGs 
and together in a mixed SG 61. Also, the endopeptidases responsible for prohormone 
processing are differentially packaged and transported81'83.
Chromogranins - Granins are a family of acidic, sulphated, calcium-binding proteins 
generally believed to be co-stored with peptide hormones and catecholaminergic 
neurotransmitters in the SGs of most neuroendocrine cells 30. The chromogranin 
(Cg)/secretogranin (Sg) family comprises predominantly CgA, CgB and Sgll. Other 
members are less widely expressed 84. Even when co-stored and co-released with 
hormones and neurotransmitters, their synthesis can be independently regulated 79, 85, 86. 
Chromogranins undergo tissue-specific processing 87 by endoproteases and their 
products are released by regulated secretion 88. Several products of granin processing 
have been identified in different cell types 89'92. The granin family is widely distributed 
in endocrine/neuroendocrine and neuronal cell types 93'95. For this reason these proteins 
are commonly used as neuroendocrine cell markers. In addition, they are also diagnostic 
markers for the development of endocrine or neuroendocrine tumors 96,91. The general 
role of granins and processing products in different cell types has not been completely
9
elucidated. Beside the already discussed role in sorting and packaging of secretory 
proteins 29,98," ,  CgA and CgB have been proposed also to act as Ca2+ accumulators in 
the SGs of neuroendocrine cells 100’101, due to their Ca2+-binding properties. Processing 
products derived from CgA, CgB and Sgll elicit autocrine, paracrine and endocrine 
effects on several organs 102~1045 often of an inhibitory nature 105. For instance, the CgA- 
derived peptide pancreastatin 106 plays an inhibitory role on Ins secretion 107, 108. Other 
CgA processed products play a role in cell adhesion 109, no. By converse, very little is 
known about the processing and function of CgB.
1.3 Molecular mechanisms o f regulated secretion
The molecular mechanisms of regulated secretion are shared by neurons and 
neuroendocrine cells, despite their different embryonic origin 62. The general model of 
regulated secretion comprises three steps: ‘docking’ of secretory vesicles to the plasma 
membrane, triggered by interactions between v- and t-SNAREs; an ATP-dependent
stage leading to partial fusion, referred to as ‘priming’, that renders vesicles competent
2+ 111 112 to Ca -triggered exocytosis; vesicle content release by opening of a fusion pore
£S)The kinetics of regulated exocytosis can vary among different cell types . An 
important difference between neuronal and neuroendocrine cells is that in the latter the 
secretion by SGs is slower (60 milliseconds to 30 seconds) and sustained, because there 
are less vesicles docked at the plasma membrane, and their mobilisation and priming is
O4. 1 |5
enhanced by Ca , whereas synaptic transmission mediated by vesicle fusion in 
neurons is very rapid (0.1 to 6 milliseconds)62,114. The molecular machinery involved 
in fusion events is composed of four families of proteins: SNARE, NSF, sec 1/munc 18- 
like and Rab proteins H1’ 115. The SNARE proteins specific for regulated exocytosis are
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the t-SNAREs syntaxin (Stx) 1 or 3 and SNAP-2, and the v-SNARE synaptobrevin 1 or 
2, also known as vesicle-associated membrane proteins (VAMP) " 6. The model of 
regulated exocytosis, that represents a variation of the common mechanism previously 
described for vesicle fusion during protein trafficking, describes the interaction between 
Rab3a and its effector Munc-18, that is normally bound to Stxl and prevents it from 
binding to SNAP-25 and VAMP. Upon stimulation of regulated exocytosis, some 
conformational changes occur that lead to the formation of a ‘core complex’ between 
Stxl, SNAP-25 and the VAMP proteins. After vesicle fusion, the core complex interacts 
with SNAPs and NSF and is disassembled upon ATP hydrolysis 18,62 (see Fig. 3 below).
T he C ore C om plex in E x o c y to s is
SynapiobreviiVVAMF
Recycling
MM
Fig. 3 — Schematic model of the exocytotic steps and of the core complex 
assembly/disassembly cycle. See text for details. Gerber and Sudhof, Diabetes 2002.
Two other regulatory proteins, the Rab3-interacting molecule (Rim) 117 and Munc-13
118, act at a post-docking step and regulate vesicle priming. Another family of proteins 
that directly interact with the core complex to regulate exocytosis, is that of the putative
11
Ca2+ sensor synaptotagmins 119. Situated on the membrane of secretory vesicles and on
0-i- 1 on 101the plasma membrane, upon Ca binding synaptotagmins can bind to Stxl and 
SNAP-25 122, inducing a conformational change that allows for vesicle fusion. 
However, their exact role is not yet completely clear 18,123.
Conformational changes in SNAREs are also modulated through phosphorylation by 
Ca2+/calmodulin kinase II (CaMKII), casein kinase II (CasKII)120, 124, 125 and the 
Ca2+/phospholipid-dependent protein kinase (PKC) 126'128.
Models o f granule fusion — Two classical models of exo-/endocytosis have been 
formulated 129131. in the first model, the so-called ‘complete fusion’, the granule lipid 
bilayer is integrated into the plasma membrane and its membrane is retrieved by 
conventional clathrin-mediated endocytosis. In the second type, referred to as ‘kiss-and- 
run’, the granule content is released through a fusion pore, that may open transiently 
and reversibly, so that it may close before complete emptying of the granule interior and 
without mixing of the granule membrane with the plasma membrane. A third type of 
exo-/endocytosis has been postulated, in which a large opening between the granule 
lumen and the extracellular space is formed, but no alteration of the granule structure 
occurs. Granules undergoing this type of exocytosis are retrieved in less than 10
seconds. This model is referred to as ‘semifusion’, and has been observed in different p
1 '10 1 0^cell lines ’ , where it has been estimated that it accounts for 90% of the release
events.
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1.4 Ins secretion
Ins secretion is a biphasic process, consisting in a sharp rise during the first few minutes 
(first phase), followed by a slower and much larger sustained Ins release (second phase), 
which lasts for at least 1 h 134. The first phase accounts for the p cell’s ability to respond 
rapidly to glucose 135. The capability of pancreatic p cells to adapt Ins secretion to the 
actual glucose concentrations arises from the features of their glucose metabolism, p 
cells express the glucose transporter Glut2 136. Once transported inside, glucose is 
phosphoiylated by glucokinase (GK) and converted into glucose-6-phosphate, which 
can enter into the glycolytic pathway. GK can be envisaged as a glucose sensor, because
1 ^ 7it couples an increase in glucose concentration to an increase in the metabolic flux
138
The events initiated by nutrient stimulation and leading to Ins release are referred to as
1 2 Q
‘stimulus-secretion coupling’ . The first product of glycolysis is pyruvate, which 
enters mitochondria and is metabolised through the tricarboxylic acid (TCA) cycle; 
substrate oxidation generates reducing equivalents that are transferred to the 
mitochondrial ETC (electron transport chain). The energy stored in the ETC as proton 
gradient generates the mitochondrial membrane potential (A\|/m), which represents the 
driving force for ATP synthesis by the ATP synthase complex (see section 2.1)! ATP is 
translocated to the cytosol by the adenine nucleotide translocator, thus increasing the 
intracellular ATP:ADP ratio 140. ATP binds to a subunit of the ATP-sensitive K+ ( K a t p )  
channels on the plasma membrane, namely the pore-forming subunit Kir 6.2, leading to 
the closure of the channel 141. This event leads to membrane depolarisation and gating 
of voltage-sensitive Ca2+ channels 142, 143. The subsequent increase in cytosolic Ca2+ 
activates Ins granule exocytosis 144'147. The events described above lie in the so-called
13
2 _j_‘triggering’ pathway of Ins release, where Ca is the main trigger of Ins secretion (Fig.
4).
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Fig. 4 - Schematic model of the stimulus-secretion coupling in p cells. Glut2: glucose 
transporter 2; mt-factor(s): mitochondrial metabolites; TCA: tricarboxylic acid cycle; 
AT'™: mitochondrial membrane potential; ATfy plasma membrane potential; UCP2: 
uncoupling protein-2. Modified from Green et al, Diabetes 2004.
Ca2+ elevation directly triggers Ins exocytosis 139, 148 and activates the intracellular 
signalling pathways that trigger and/or potentiate its release. Beside the triggering 
pathway, there is a glucose-induced ‘amplifying’ pathway, which is activated along 
with glucose metabolism and enhances Ins release (see below). The intracellular 
messengers activated by both the triggering and the amplifying pathway and their 
effectors have not been completely identified, however the following signalling 
pathways are clearly implicated in Ins secretion stimulated either by nutrients, or by 
neurotransmitters and hormones: PCK, CaMKII, nucleotide-dependent protein kinase 
(PKA). PKC is regulated by diacyl glycerol (DAG), which is generated either by de
14
novo synthesis 149 or by phospholipid hydrolysis upon phospholipase C (PLC) activation 
15°. PKC acts at distal steps of the exocytosis through indirect or direct effects (Munc-18 
phosphorylation 127). The other product of phospholipid hydrolysis, inositol 
trisphosphate (1P3), mobilises intracellular Ca2+-stores by binding to its receptors on the 
ER membrane 151, thus further elevating Ca2+ levels. Ca2+ elevation activates CaMKII 
b2, 15j, associated with Ins SG 154, which is implicated in final secretory steps such as 
granule fusion and mobilisation 155, 156. Glucose stimulation also induces an increase in 
cAMP levels by activating adenylate cyclase, which in turn leads to enhanced activity of 
PKA 153’157. PKA appears to be involved in distal exocytotic steps l58.
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Fig. 5 -  Schematic model of the intracellular pathways involved in Ins secretion.
VDCC: voltage-dependent calcium channel; PIP2: phosphatidyl inositol bisphosphate; 
for the other abbreviations see the text. Personal elaboration of the statements presented 
in the Introduction section.
The KATP-dependent mechanism (triggering pathway) only accounts for the first phase 
of Ins secretion, whereas it seems clear that the second phase response is not mediated 
by Ca2+ elevation l39. The glucose-induced amplifying pathway accounts for the second 
phase of Ins secretion. This amplifying pathway comprises two components: a Ca2+-
15
dependent, KATP-independent pathway 160 162 and a Ca2+-independent, KATP-independent 
one 139, 163. The latter involves the PKC- and cAMP-mediated signalling 164, 165, while 
the former is related to coupling factors generated through nutrient metabolism 140,147’ 
166. Anaplerosis, defined as the refilling of TCA cycle intermediates, and cataplerosis,
i.e. the efflux of TCA intermediates and their metabolites from the mitochondrion to the 
cytosol also play a role in Ins secretion 167, 168, possibly via the KATP-independent 
pathway 166, involving either malonyl-CoA 169, glutamate 170 or ATP/GTP 171 as 
coupling factors.
Granule pools in pancreatic ft cells - The biphasic nature of Ins secretion may be
■j <2 q -I
explained with the existence of distinct pools of Ins granules ’ . Like in other
secretory cell types, pancreatic (3 cell granules exist in at least two distinct pools: the 
docked or ‘ready-releasable’ pool (RRP), from which they are promptly and rapidly 
exocytosed, and the ‘reserve’ pool, that becomes releasable after a recruitment step. 
Within the docked population there are two subsets: one of ‘immediately releasable’ 
primed granules, and another one of ‘ready releasable’ unprimed granules 173’ 174. It has 
been estimated that (3 cell contains on average 10,000-12,000 granules in the reserve 
pool, while only 10% of the total number is in the docked state, and the 0,2-1% (50-100 
granules) is immediately releasable 133, 175. This small pool of granules is envisaged to 
account for the rapid exocytotic burst of the first phase Ins secretion 176’ 177. The second 
phase requires the refilling of the emptied pool with granules already docked at the 
plasma membrane. The metabolic requirements of the two phases of Ins secretion (Ca2+- 
dependency and energy dependency, respectively) are mirrored by the properties of the 
granules pools 112,158.
To make the picture more complex, a third granule pool has been described according to
17Rits electrophysiological properties, named ‘highly calcium-sensitive’ pool (HCSP)
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179, that is very small but is markedly increased in response to global Ca2+ elevations. 
On the same line, a small (around 10%) subset of the reserve pool, capable of fast, long­
distance movements 18°, has been shown to be differently regulated by Ca2+ as 
compared to the majority of granules in the reserve pool (namely, they appear to be 
regulated by different Ca2+ pools: the fast granules respond to Ca2+ elevations mediated 
by Ca2+ influx through voltage-gated Ca2+ channels, while the slow granules are 
regulated by Ca2+ efflux from the ER). This pool has been suggested to act as an
intermediate pool that enables refilling of the RRP during the second phase Ins secretion
181, but a conclusive correlation between this SG pool and its content has not been 
drawn.
From ft cell physiology to pathology -  The molecular mechanisms underlying 
neurosecretion, from protein synthesis and granule biogenesis to the final steps of 
exocytosis, are tightly regulated. The picture is even more complex in pancreatic (3 cells, 
where the unique correlation between stimulation of Ins secretion and metabolism leads 
to a biphasic release. According to what has been presented in the previous section, 
several crucial steps can be envisaged in pancreatic (3 cell function, such as Ins 
processing and folding, mitochondrial nutrient metabolism, Ca2+ homeostasis, 
intracellular signalling.
In the next sections we will describe two major perturbations of cell homeostasis, the 
oxidative stress and the ER stress that play a crucial role in cell dysfunction and have 
been correlated to pathological conditions of pancreatic p cells, such as hyperglycemia 
and diabetes.
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2. Oxidative stress
2.1 Role and generation o f ROS
Redox homeostasis - Oxidative stress is defined as a serious imbalance between the 
production of reactive species and antioxidant defences 182, leading to potential tissue 
damage. Reactive species, either deriving from oxygen (ROS) and nitrogen (RNS), are 
highly reactive molecules. These include superoxide (O 2’), hydroxyl radical (OH), 
hydrogen peroxide (H2O2) and nitric oxide (NO). The concentration of reactive species 
is maintained at low levels by antioxidants, compounds capable of competing with other 
substrates, thus delaying or inhibiting their oxidation. Endogenous antioxidants include 
superoxide dismutase (SOD), catalase, ascorbate, glutathione, and less specific 
compounds, such as free amino acids and proteins, whose scavenging activity is related 
to oxidation-induced proteolysis 183.
At moderate concentrations ROS may act as regulatory mediators in physiological 
processes, for instance regulation of vascular tone or signal transduction from 
membrane receptors. However, most reactive species play an important role in 
signalling processes implicated in protective responses against oxidative stress, that re­
establish the balance between ROS production and scavenging activity, i.e. the so-called 
redox homeostasis. When ROS production is significantly and persistently increased, 
the system can still reach an equilibrium, associated with higher ROS concentrations and 
different patterns of gene expression, which does not necessarily lead to a pathological 
condition. This occurs for example in the process of aging. Pathological conditions 
develop in a situation of chronically increased ROS levels 184.
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Several endogenous sources of ROS can be envisaged in all cell types and in particular 
in secretory cells: mitochondria, NADP(H) oxidase and the secretory pathway itself. 
Mitochondria - The largest production of ROS takes place in the mitochondria: their 
generation is directly linked to the mitochondrial activity, which is therefore tightly 
regulated by substrate availability, Ca2+ uptake 185 and feed-back inhibition through 
NADH 186, ATP and citrate 184. During mitochondrial respiration, molecular oxygen is 
consumed for the complete metabolism of glucose and other substrates, leading to the 
production of ATP. Substrate oxidation along the TCA cycle leads to reduction of the 
carriers NAD+ and FADH, which in turn provide electrons to the ETC on the inner 
mitochondrial membrane. The ETC is formed by four inner membrane-associated 
enzyme complexes, cytochrome c (cyt c) and the mobile electron carrier ubiquinone
• i on
(Fig. 6) . The electron flow through the ETC generates an electrochemical gradient
(Apn+) across the inner mitochondrial membrane that is used to drive the extrusion of 
protons from the mitochondrial matrix 185, 186. The A\|/m is created by the ETC and is 
negative inside. ATP synthase (complex V) in the mitochondrial membrane uses the 
energy stored in the Apn+ to catalyse the production of ATP from ADP. Although the 
mitochondrial ETC is very efficient, it is intrinsically prone to some electron leakage 
through side reactions between each electron carrier and molecular oxygen 188. Such 
side reactions generate O2" 189’ 190, which dismutates to H2O2 , that if not detoxified can 
be converted to OH 191. It has been estimated that during oxidative phosphorylation up 
to 4% of the oxygen consumed gives rise to ROS. The outer mitochondrial membrane is 
also a source of H2O2 through the enzyme monoamine oxidase 188.
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Fig. 6 -  Schematic representation of the mitochondrial respiratory chain. C y t  c:
cytochrome c; I-IV: complexes of the ETC; Agn+: proton electrochemical gradient. 
Brownlee, Nature 2001.
NAD(P)H oxidase - Another relevant source of ROS, which has not been intensively 
investigated in pancreatic (3 cells 192, 193, is the NAD(P)H oxidase 184’ 194. Initially 
characterised in macrophages and neutrophils ]9*, NAD(P)H oxidase is a heme- 
containing protein complex, comprising a plasma membrane-bound cytochrome 6558 
complex and three cytosolic components. Its assembly and activation occurs upon 
translocation of the cytosolic components to the cytochrome 6558 complex 196,197. The 
NAD(P)H oxidase isoforms of non-phagocytic cells produce O2' at a low, but sustained 
rate 1%. NAD(P)H oxidase activity is tightly regulated by the cytosolic signalling 
molcule rac 198, 199 and its regulatory proteins Tiam-1 (T-lymphoma invasion and 
metastasis 1) 200 and RICS (Rho GAP involved in the B-catenin-N-cadherin and NMDA 
receptor signalling; NMDA = N-Methyl-D-aspartate) 201. Other regulatory proteins of 
the NAD(P)H oxidase components are PKC 200’202-204 ancj CaMKII 200’201. Upon stress 
conditions, such as hyperinsulinemia, hyperglycemia and fatty acids (FA) exposure, 
NAD(P)H oxidase activity is up-regulated 205.
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The secretory pathway - Another physiological source of ROS and possible cause of
ona onooxidative stress is the protein folding process that occurs in the ER ’ . The
208  209formation of disulfide bonds, catalysed by the protein disulfide isomerase (PDI) ’ ,
is essential for the folding and stability of many secretory proteins, including Ins. The
210 211disulfide formation is a redox-dependent process, driven by a protein relay ’ that 
involves PDI and Erol 212, a FAD-dependent enzyme. Erol oxidises PDI, which in turn 
oxidises disulfide bonds in folding proteins. Erol can then couple its re-oxidation to the
•  206  207  211reduction of molecular oxygen: as a result, its activity may generate ROS 
The balance between oxidised and reduced equivalents in the ER is maintained by the 
transport of oxidised glutathione from the cytosol into the ER lumen 2I0’ 21J. A 
summarising model is depicted in Fig.7.
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Fig. 7 -  Schematic model of the protein relay implicated in disulfide bound 
formation. GSH: oxidised glutathione; GSSG: reduced glutathione. Modified from 
Frand et al, Cell Biology 2000.
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Considering that up to 80-90% of proteins synthesised in secretory cells may be 
destined for secretion, it has been estimated that Erol-mediated oxidation could account 
for a high fraction of cellular ROS produced during protein synthesis 206.
2.2 Oxidative stress
Upon a strong, persistent perturbation of the redox homeostasis the cells activate the so- 
called oxidative stress response. Excessive levels of ROS may be generated either by 
increased stimulation of NAD(P)H oxidases or by other mechanisms (i.e. mitochondria). 
At high concentrations, ROS and RNS directly oxidise and damage DNA, proteins and 
lipids. In particular, due to its close proximity to the mitochondrial inner membrane, the 
mitochondrial (mt)-DNA is a target of ROS attack 185, 186 and some mutations can be 
induced, whose accumulation leads to mitochondrial dysfunction. ROS and RNS can 
also indirectly damage tissues by activating a number of cellular stress-sensitive 
pathways, which may lead to changes in gene expression, perturbation o f the 
intracellular Ca2+ homeostasis, activation of endonucleases and eventually apoptosis 214. 
High and sustained levels of ROS have been implicated in the pathogenesis of cancer, 
diabetes mellitus, atherosclerosis and other diseases 184.
Uncoupling proteins -  A protective role against oxidative stress may be played by the 
so-called ‘uncoupling’ proteins (UCPs), which in certain cell types account for an 
inducible proton leak from the mitochondrial ETC 215. This mechanism is distinct from 
a basal proton leak, present in all cell types, that dissipates a part of the energy stored in 
the proton gradient. Upon uncoupling, the energy of the electrochemical gradient is not 
used for ATP synthesis, but results in heat production. Three UCPs, namely UCP1, 
UCP2 and UCP3, have been identified 216. UCP-1 or thermogenin, that is typical of
22
brown adipose tissue (BAT), is involved in thermoregulation in newborns and
917 71o
hibernating animals . UCP2 mRNA has been found in many tissues , although the 
protein is not expressed in all. UCP3 is restricted to BAT and skeletal muscle 219. Beside 
the uncoupling function of UCP2 and UCP3, there is some evidence for a role as anion 
transporters (for free FA for example) 22°. Both these functions may play an important 
role in protecting cells from oxidative stress. In conditions of high substrate availability 
but limited oxidising capacity, for instance, electrons exit the ETC and generate ROS. 
An uncoupling activity, causing a faster electron flow and lowering A\j/m, would 
decrease ROS formation. Besides, as anion carriers, UCP2 and UCP3 might transport 
O2’ and therefore protect mitochondria from ROS. Upon oxidative stress UCP2 mRNA 
and protein expression increases 218: this appears to be a rapid response to oxidative 
stress. Moreover, UCPs are activated by O2’ 221. Thus, UCP2 and UCP3 have been 
suggested to play a role in decreasing the A'Fm and consequently the production of O2' 
in oxidative stress conditions.
2.3 Mitochondria and oxidative stress
Mitochondria are an important target of the oxidative stress-induced damage, that 
causes a decrease in ATP production, a perturbation of Ca2+ homeostasis, and the 
induction of mitochondrial permeability (defined as the opening of a ‘megapore’ in the 
mitochondrial inner membrane) which leads to the breakdown of the AxPm 186. All these 
events may lead to cell death 222.
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Mitochondria may alter their shape to adapt to new environments. In normal conditions 
their shape is dynamic 223 and they can undergo fusion and fission events. When cells 
require a large amount of ATP, mitochondria become granular and separated, thus 
increasing their surface area. When less ATP is required they form filamentous 
structures and decrease their surface area 224. Under unfavourable conditions 
mitochondria undergo two types of structural changes: a simple swelling or the 
formation of megamitochondria (MG). Mitochondria become two to three times larger 
in size by simple swelling, whereas beyond those extents they can be classified as MG. 
MG formation can be envisaged as an adaptive process. They may generate less 
amounts of ROS because of lower respiration rates and oxygen consumption, and the 
decrease of ATP production induces growth arrest. If  mitochondria succeed in 
suppressing intracellular ROS levels, they can return to normal structure and 
functionality. However, upon chronic oxidative conditions, MG become swollen, the 
A\|/m is lowered, intracellular ATP levels decrease and several pro-apoptotic proteins, 
including cytochrome c, are released from the mitochondria because of the membrane 
permeability increase, leading to activation of caspases and induction of apoptosis 224,
225
Alterations of the protein machinery implicated in fusion and fission and mitochondrial 
morphology (i.e., swollen or fragmented mitochondria) are associated with some human 
diseases 226>227? including type 2 diabetes 228>229.
Calcium and mitochondria. It is widely accepted that mitochondria play an important 
role in the intracellular Ca2+homeostasis: oxidative metabolism and ATP production 185, 
ER-mitochondria Ca2+ signalling, apoptosis 230, 231, and possibly every signalling 
pathway, are associated with mitochondrial Ca2+ uptake. Ca2+ flux into the mitochondria 
represents only a small fraction of the cytoplasmic Ca2+ flux during Ca2+ redistribution
24
in the cytoplasm 232. Nevertheless, the contribution of mitochondrial Ca2+ flux is 
functionally very relevant.
The A\|/m is the driving force for mitochondrial Ca2+ influx, and must be tightly
'S 'j A  sy i /}_i_
regulated . In resting conditions the mitochondrial Ca content is low; Ca uptake is
^ I
mediated by specific transporters, and since there is no counter-ion for Ca , the 
mitochondrial membrane becomes depolarized 233. The subsequent increased rate of 
ATP production is thought to restore A\pm. There are two mechanisms for Ca2+ entry in 
mitochondria which are still undefined at the molecular level: a ‘uniporter’ 234,235 and a 
‘rapid uptake mode’ (RaM) 236, which responds to small, rapid Ca2+ concentration 
changes 236. There are also two distinct mechanisms of Ca2+ efflux: a Na+-dependent 
and a Na -independent transport systems . In addition, Ca might be released from 
mitochondria through the permeability transition pore (PTP), a channel o f unknown
• • 'J'XQ 9^ 0identity ’ , the opening of which is enhanced by a reduction of the A\\fm, elevated
matrix [Ca2+] and increased matrix pH.
Mitochondria can form networks or clusters connected with intermitochondrial 
junctions. The mitochondrial network is an electrically continuous system that 
facilitates energy delivery and may organise antioxidant defence 240. Mitochondrial Ca2+ 
uptake takes place at preferential sites associated with the ER, and it diffuses along the 
network during maximal stimulation 231.
Mitochondria and ER - In several cell types a close apposition of mitochondria with ER 
can be observed 241. Subdomains of the sarco/endoplasmic reticulum (SR/ER) are in 
close contact with mitochondria (Fig. 8): in these discrete areas there is a concentration 
of Ca2+ release sites (IP3-gated channels 242 or ryanodine receptors 243), which are next 
to mitochondrial Ca2+ uptake sites 238. This apposition between ER and mitochondria is 
dynamically regulated by Ca2+244. The functional association of ER and mitochondria is
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involved in intracellular Ca homeostasis and in the induction of apoptosis. Concerning 
the former, in pancreatic (3 cells a perturbation of mitochondrial functionality leads to 
emptying of the ER Ca + stores and impairment of Ins secretion 24r). With respect to the 
latter, mitochondrial Ca~+ overload in a situation of high ER Ca2+ release (induced for 
example by C2 ceramide) activates the apoptotic pathway, induces mitochondria 
swelling and rupture of the mitochondrial network 246.
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Fig. 8 -  Apposition between ER and mitochondria. Electron microscopy image 
illustrating (arrows) the close apposition of mitochondria (m) and endoplasmic 
reticulum (er). nu: nucleus. Detail from Hajnoczky et al, Journal of Physiology 2000.
2.4 Oxidative stress and (3 cells
Formation of ROS and RNS has been associated with p cell dysfunction and/or cell 
death in both type 1 l84,247,248 and type 2 diabetes 249-25In addition, ROS-induced 
stress pathways are responsible for the secondary complications associated with 
diabetes 247>252’253. g  cells have lower antioxidant defences as compared to other tissues 
and are therefore particularly sensitive to the oxidative stress-induced damages.
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As previously illustrated (section 1.4), mitochondrial metabolism is crucial in Ins 
secretion 146,254, and mitochondria are both a source of free radicals and their targets. 
Thus, oxidative stress and ROS-induced mitochondrial dysfunctions lead to impaired 
Ins secretion 191, 255. Another possible direct target of ROS in p cells might be 
glucokinase 191 that is inactivated by oxidation 256.
Once diabetes is overt, chronic hyperglycemia leads to a vicious cycle of continuous 
perturbation of p cell function, by impairing glucose-induced Ins secretion and Ins gene 
expression 257 and causing chronic oxidative stress 258, 259. During chronic 
hyperglycemia, p cells activate an antioxidant compensatory response that may lead to 
adaptation and survival 260, however in some cases they fail to trigger the compensatory
9 f \  1response . Besides high glucose, chronically elevated levels of FA, which are also 
essential p cell fuels in normal conditions, lead to impairment of Ins secretion 262 and
9 ft 'XIns gene expression and to ROS production, for instance by increasing mitochondrial 
uncoupling 264.
Ins secretion as a possible source o f ROS - B cells are not only a target of oxidative 
stress: they may also be envisaged as a source of ROS. It has been postulated that 
oxidative stress in pancreatic P cells may be tightly linked to glucose-stimulated Ins 
secretion (GSIS) 265. According to this hypothesis, three players are implicated in ROS 
generation: increased glycolytic flux, ATP:ADP ratio and intracellular Ca2+ 
concentrations.
Glucokinase stimulates a steep increase of the glycolytic flux and a strong enhancement 
in the production of reducing equivalents 266. In addition, increased FA oxidation could 
further increase the production of reducing equivalents.
Upon increase of the glycolytic flux, the increased A\j/m induces a reduced state of the 
carriers along the ETC, thus increasing ROS production 19°. The value of A\j/m also
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depends on the ATP production rate and, in particular, on free ADP concentration, that 
has been shown to decrease dramatically upon glucose stimulation 261. A decrease in 
free ADP concentration leads to decreased ATP production, which in turn increases 
A\|/m and, subsequently, ROS production.
2+
The third player of p cells ROS production would be the elevation of intracellular Ca 
levels. Ca2+ accumulation in mitochondria is believed to stimulate mitochondrial 
generation of ROS 268.
ROS production may therefore be a fast event tightly coupled with glucose metabolism; 
however, oxidative stress can be observed after days of exposure to Ins secretagogues. 
UCP2, oxidative stress and Ins secretion - Uncoupling protein UCP2 is expressed in 
pancreatic p cells. Its role is still debated, and three main functions have been 
suggested: negative regulation of Ins secretion, defence against oxidative stress and 
regulation of fat homeostasis 269’270.
071 OAQBoth knocking-down and over-expression of UCP2 in pancreatic islets affect 
ATP levels, A\|/m and glucose-stimulated Ins secretion 269. The absence of UCP2 seems 
to lead to a higher degree of coupling in the mitochondria of p cells and to improved Ins 
secretion.
As expected because of its function as an uncoupler, the over-expression of UCP2 also 
enhances the resistance of p cells toward ROS toxicity 272. As previously discussed 
UCP2 protein levels are enhanced upon high glucose- and free FA-induced oxidative 
stress 218’273,274. In addition, mitochondrial O2 ' activates UCP2-mediated proton leak. 
However, these protective mechanisms against oxidative stress also decrease the rate of 
ATP production and the corresponding ATP:ADP ratio, leading to impaired glucose- 
stimulated Ins secretion, as observed in type 2 diabetes 221’275.
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The third hypothesis related to UCP2 function is the regulation of fat homeostasis. In 
order to optimise Ins secretion, the lipid content in pancreatic p cells must be carefully 
regulated ’ . UCP2 gene expression is up-regulated upon stimulation of the
peroxisome proliferator-activated receptor y (PPAR-y) 278, that binds to non-esterified 
FA. This supports a role for UCP2 in the intracellular fat homeostasis in p cells, as in 
other tissues 279. Indeed, chronic exposure to FA leads to Ins secretion impairment, 
decrease in A\|/m and ATP:ADP ratio, and over-expression of UCP2 at the level of both 
mRNA and protein 274,280. This role of UCP2 in fat homeostasis points to a protective 
role of UCP2 in the framework of fatty acids-induced ROS generation.
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3. ER stress
3.1 The unfolded protein response
Beside oxidative stress, another stress response has been observed under diabetic 
conditions in several tissues, including pancreatic p cells, i.e. the so-called ER stress, 
defined as a perturbation of ER homeostasis 28 *. The two stress responses are thought to 
be correlated 207’ 282, in particular with regard to the ER redox balance 206 (see section 
2.1), although a causal relation has not been established yet.
As discussed in section 2.1, the ER is the organelle responsible for synthesising 
secretory and membrane proteins, that are post-translationally modified and folded in its 
lumen. It is also the major intracellular Ca2+-store. Newly synthesised proteins are 
folded and assembled in a process facilitated by chaperones within the ER lumen. 
Chaperone activity 283 and inter-molecular electrostatic interactions 284 largely depend 
on Ca . Proteins in the ER undergo a strict ‘quality control’ , so that partially or 
incorrectly folded proteins are recognised and bound by chaperones such as BIP 287, 
calnexin and calreticulin 288. This ensures their retention in order to complete the 
folding, and in case of failure they are transported to the cytosol and undergo 
proteasomal degradation 288. Upon stressful conditions, such as for instance an overload 
of misfolded proteins, a perturbed redox balance or an altered Ca2+ concentration, the 
ER fails to export correctly folded proteins and a stress-induced signalling cascade is 
activated that leads to the so-called ‘unfolded protein response’ (UPR), aimed at 
restoring physiological conditions. The UPR is a transcriptional and translational 
signalling pathway encompassing four distinct responses. Firstly, chaperone expression 
is induced to enhance ER protein folding capacity, while at the same time the overall
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rate of transcription and translation is reduced with a concomitant decrease in the
9RQbiosynthetic rate . A further response consists of an increased ER-associated 
degradation (ERAD) of misfolded proteins 290’291. Finally, if the previous mechanisms 
fail to re-establish a physiological situation, the apoptotic pathway is triggered. UPR 
can also be activated in non-stressed conditions, where it is thought to be involved in
909 909the control of nutrient fluctuations ’ (see below). Moreover, some physiological 
conditions can be mediated by ER stress induction, as exemplified by the differentiation 
of B cells into plasma cells 294>295.
BIP - The most important chaperone implicated in ER stress sensing and UPR induction 
is BIP. This chaperone, which belongs to the heat shock protein (Hsp) family, is an 
essential component of the translocation machinery that is responsible for bringing the 
newly synthesised peptides into the ER lumen; it also plays a role in retrograde 
transport across the ER membrane of aberrant proteins destined for proteasomal 
degradation 296. Most importantly, BIP binds to unfolded proteins 287. It exists in two 
forms, as a monomer and as an oligomer. In the monomeric form, BIP associates with 
unfolded proteins 297, which appear to enhance its conversion from the oligomeric pool 
into the monomeric active form 298 as well as to enhance BIP synthesis. The increase in 
the amount of monomeric BIP is the first event of the UPR and represents a mechanism 
for sensing the accumulation of unfolded proteins in the ER lumen. The unfolded 
protein signal is then transduced through the ER membrane by three trans-membrane 
proteins (IRE1, PERK, ATF6; Fig. 9), that in physiological conditions are maintained in 
an inactive state by BIP binding 299, 300. Upon stress induction, in order to face the 
increased need of protein folding, BIP dissociates from the three transducers, thus 
allowing their activation. In its unbound form, IRE1 (inositol requiring 1/ERN1 [ER to 
nucleus signalling 1]) dimerises and can bind other proteins along the ER stress signal
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transduction pathway . PERK (double-stranded RNA-activated protein kinase fPKR]- 
like endoplasmic reticulum kinase/PEK [pancreatic eukaryotic initiation factor 2a 
(eIF2a) kinase) can sensor and transduce the ER stress signal with a common
0^9 •mechanism, i.e. by stable dimerisation . ATF6 (activating transcription factor 6) is 
translocated from the ER membrane to the GC upon stress sensing, by way of two 
independent signal sequences that are unmasked after dissociation of BIP l03,304.
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Fig. 9 -  Schematic model of the interaction between the ER stress sensor BIP and 
the three trans-membrane signal transducers IRE1, PERK and ATF6. See text for 
details. Zhang and Kaufmann, Journal of Cell Biology 2004.
The UPR activated by unfolded proteins signal transduction consists of a signal 
transduction cascade that involves different pathways, triggered by IRE1, PERK and 
ATF6 (Fig. 10).
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Fig. 10 -  Schematic model of the signalling pathways induced by IRE1, ATF6 and 
PERK. A: IRE1 and ATF6 pathways; B: PERK pathway. See text for details. Zhang 
and Kaufmann, Journal of Cell Biology 2004.
IRE1 - IRE1 shows kinase 3(b and endoribonuclease activity, the latter being induced 
upon oligomerisation by the former. IRE1 endoribonuclease activity induces splicing of 
a small intron from the transcription factor XBP-1 (X-box binding protein) mRNA. 
While the unspliced form of XBP-1 is degraded by the proteasome, the spliced form 
accumulates and shows an enhanced transcriptional activity 294. The target of XBP-1 is 
a subset of genes encoding for ER chaperones j06, that are bound by XBP-1 in the so- 
called ‘UPRE’ (unfolded protein response element) or in the ‘ERSE-IE (ER stress 
response element II) on their promoters j07. These target genes include Herp, the most 
highly inducible gene under ER stress j08, and EDEM (ER degradation-enhancing a- 
mannosidase-like protein), a protein complex implicated in the ER quality control that 
interacts with misfolded proteins and accelerates their degradation via ERAD l09.
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PERK -  PERK is a kinase whose mRNA is predominantly expressed in the pancreas,
and the protein only in pancreatic islets 31°. Its oligomerisation, which occurs upon
dissociation of BIP, induces phosphorylation of its substrates, the transcription factors 
1^0 1^1eIF2a and N rf . The latter is implicated in the survival response. Upon activation 
and nuclear translocation, N rf binds to the ‘ARE’ (antioxidant response element) of its 
target genes, that encode detoxifying enzymes 312. eIF2a normally initiates protein 
translation by delivering the initiator-tRNAMet to ribosomes. Its phosphorylation by 
PERK results in the inhibition of translation. Upon such attenuation, only specific 
mRNAs are translated 313, including ATF4 (Activating Transcription Factor 4) 314, that 
in turn induces the transcription of genes involved in amino acids metabolism, oxidative 
stress specific gene expression and ER stress-induced apoptosis. Some targets of ATF4 
are CHOP, GADD34 and ATF3: CHOP (C/EBP homologous protein)/GADD153 is a 
pro-apoptotic factor 307’315 (see below); GADD34 is responsible for a feed-back loop316,
T17 that removes the eIF2a-induced translational block; ATF3 activates GADD34 and 
CHOP transcriptional activation, thus coordinating the ATF4 response318.
ATF6 -  Upon translocation to the GC, the basic leucine-zipper transcription factor 
ATF6 is cleaved by the proteases SP1 and SP2 319. The fragment released after cleavage 
moves into the nucleus 320 and binds to the ERSE 321 and ERSE-II 322 on the promoters 
of the target genes. ATF6 regulates transcription of many important ER stress genes, 
including BIP, CHOP, XBP-1 and Herp 322'324.
Coordination o f UPR -  The different branches of the UPR converge onto common 
downstream targets, such as CHOP 307’ 308, 325,326. The interaction among the UPR- 
induced transcription factors can act as a positive or a negative control on the UPR 
itself. Importantly, there is a temporal sequence in the UPR 327. The PERK pathway is 
quickly activated, and the ATF6 pathway is activated before that of XBP-1, thus
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allowing the cell to face the ER stress through an increased protein folding. Only later, 
if the stress is prolonged, XBP-1 is produced and the refolding is coupled to protein 
degradation 328.
Apoptosis - When ER functions are severely impaired, the cell must be eliminated by 
apoptosis. A central pathway in ER stress-induced apoptosis is the activation of 
caspase-9 upon mitochondrial cytochrome c release, mediated by pro-apoptotic factors 
such as Bax, Bak and Bad on the mitochondrial membrane. Another major ER stress- 
specific apoptotic pathway is the activation of caspase-12, triggered by direct 
interactions of IRE1 and by the massive Ca2+ release from the ER, that is mediated by 
the aforementioned pro-apoptotic factors on the ER membrane. Alternative pro- 
apoptotic cascades such as ASK1 (a stress-activated MAP3 kinase) 329 and JNK (c-jun 
N-terminal kinase) 330 are activated by the IRE1 pathway. Ca2+ released by ER is 
rapidly taken up by mitochondria, thus inducing collapse of A'Fm and induction of 
apoptosis 331. In this picture, the ER stress-induced pro-apoptotic factor CHOP 
suppresses the expression of the anti-apoptotic factor Bcl-2, thus shifting the balance 
between anti-apoptotic and pro-apoptotic factors towards the latter327’332.
3.2 ER stress and Ins secretion
Pancreatic (3 cells have a highly developed ER and are subject to a massive protein 
synthesis and secretion. The expression of IRE1, PERK and BIP in p cells is high 
compared to other tissues, which might reflect the need for a strict quality control of 
protein folding. Indeed, malfolding leads to apoptosis 333, as exemplified by the Akita 
mouse, a spontaneous diabetic model 334 which carries a mutation in the insulin 2 (Ins2)
35
gene, that disrupts a disulfide bond formation between the A and B chain. This has a 
strong impact on ER homeostasis and leads to apoptosis through CHOP induction 315, 
. The Akita mouse model has shed some light on the relevance of ER stress in 
diabetes and in particular in the decrease in p cell mass that is a feature of both type 1 
and type 2 diabetes . The increased Ins demand in conditions, such as obesity or Ins 
resistance, produces ER overload and may lead to chronic ER stress, with consequent 
induction of apoptosis.
A central player in pancreatic p cell function is PERK, whose functional alterations
ooo 'X'xn ooclead to type 2 diabetes ’ ’ . PERK is physiologically active at low glucose
concentrations 339. Due to the glucose-dependent translational control of proins 340, in 
conditions of low Ins demand proins translation is attenuated. The PERK-induced eIF2a 
phosphorylation is implicated in such negative regulation of translation 292, 337, whereas 
under increased glucose levels the UPR is turned off and proins translation enabled, at 
least until an ER overload induces again UPR and translational attenuation. Thus, Ins 
synthesis appears to be coupled with ER folding capacity through UPR, and PERK 
plays a crucial role in this regulation, preventing ER stress and ensuring the 
maintenance of p cell function 338.
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A IM S
The aim of the work presented in this thesis was to investigate under physiological and 
stress conditions Ins- and CgB-contanining secretory granules in p cell models. This 
aim was pursued by:
1. assessing the intracellular distribution and the secretory behaviour of Ins and 
CgB in two rat, INS1-E and Rin-5AH, one mouse, P-TC3, p-cell lines and in 
human purified islets under physiological conditions;
2. reducing the complexity of the Rin-5AH population by subcloning and by 
drawing correlations between the poor Ins secretory behaviour displayed by 
RIN-5AH cells, and in particular the Q2 subclone derived thereof, and oxidative 
stress features such as mitochondrial status;
3. studying the effects of ER stress on Ins and CgB secretion in the INS1-E p-cell 
model and in Rin-5AH and Q2 cells.
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RESU LTS
1. Ins and CgB granules in ft cell models
The co-existence of different secretory products within the same granule 63,64, as well as 
the packaging of secretory proteins in different granules, has been documented in 
different cellular systems 67, 77,80 but has so far not been extensively investigated in 
pancreatic p cells, nor it has been studied with regard to a possible differential control of 
SGs storing of different secretory products. Besides hormones and neurotransmitters 
polypeptides belonging to the Cg family are markers of SGs in both neurons and 
neuroendocrine cells 93~95. Traditionally, these proteins and their processing products 
have been considered to be co-stored, and co-secreted along with the hormones and 
transmitters from the same SG 30,63,69. In pancreatic p cells the main secretory product, 
Ins, largely co-localises with CgA 68, 69. While CgA has been characterised in p cells 
from the point of view of its intracellular localisation, processing and secretion, little is 
known about the other member of the granin family, CgB.
A series of experiments was undertaken to investigate:
• the sub-cellular localisation of CgB in different p cell models
• whether and to what extent Ins and CgB are co-stored within the same SGs
• how Ins and CgB are distributed with regard to the architecture of the SGs
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• whether Ins and CgB are always co-released, or can be discharged independently 
from each other.
1.1 Dissociation o f Ins and CgB in the SGs o f various B cell models: 
immunofluorescence
In order to establish whether Ins, and the granin CgB are stored together or in separate 
SGs, we investigated a number of well known Ins-secreting cell lines together with 
isolated human islet cell preparations, by using a battery of antibodies against the two 
proteins and intracellular organelle markers. First of all we noticed that the confocal 
analysis (Fig. 1A), even when associated to tridimensional reconstruction, gave 
unsatisfactory results in terms of granular staining, while enhancing the signal from 
compact structures, such as the GC. Moreover, the resolution of confocal images at high 
magnification was not satisfying. We therefore improved the image quality by using the 
Deltavision™ wide-field microscopy system, which couples the acquisition of optical 
sections along the z-axis with deconvolution analysis and tridimensional reconstruction 
(Fig. IB).
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Fig. 1 - Comparison between confocal analysis and wide field acquisition followed 
by image deconvolution. Immunostaining of INS1-E cells with Ins (red), CgB (green) 
and TGN38 (blue). Panel A: Confocal image acquired with a Leica TCS-SP2 
microscope; Panel B: acquisition with the Deltavision™ system. Scalebar: 6pm.
Fig. 2 shows the results with the various investigated p cell types. In the rat line INS1-E 
(Fig. 2 A,A’-C ,C ’) a large extent of co-localization between Ins and CgB was observed 
in the perinuclear area of the TGN labelled by the specific marker, TGN38 (Fig. 2 
A,A’), and also in the GC, revealed by the specific marker GM130 (Fig. 2 B,B’). In 
contrast, many of the discrete dots scattered at the periphery of the cytoplasm, 
corresponding to SGs, were immunolabelled only for either one of the secretory 
proteins (Fig. 2 A,A’-B,B’). The considerable dissociation at the level of SGs was 
confirmed also when, instead of Ins, we compared the distribution of CgB with that of a 
specific p-SG marker, the single span membrane protein IA-2/ICA-512 (Fig. 2 C,C’). A 
strong co-localisation of Ins and IA-2/ICA-512 was also observed in p-TC3 cells (Fig. 
2L ). Also CgA, the granin most often investigated in p cells, largely co-localised with 
Ins in INS1-E cells (Fig. 21).
In the other two Ins-secreting lines investigated, the rat RIN-5AH (Fig. 2 D,D’-F ,F ’) 
and the mouse p-TC3 insulinoma (Fig. 2G), the dissociation between Ins and CgB at the 
level of SGs appeared even larger than in INS1-E cells. Similar results were obtained in 
preparations of isolated human islet cells (Fig. 2 H,FP), where CgB was expressed not 
only in the Ins-positive p cells, but also in other cells that we did not investigate for 
endocrine function.
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Fig. 2 - Analysis of rlie 
intracellular distribution of 
Ins and CgB in p cell lines 
and human islets.
Deconvolution of immunofluorescence images of different p cell models, INS1-E 
(panels A -  C and I), Rin-5AH (panels D -  F), (3-TC3 (panel G and L) and isolated 
human islets (panels H). Cells were stained with anti-ins (red), anti-CgB (green) and a 
third marker (blue). Panels A, B, C, D, E, F and H show overviews of the cell 
populations. The enlargements of the contoured areas are shown in panels A’, B’, C’, 
D’, E’, F’ and FT. Clear co-localisation of Ins and CgB is evident in the TGN (TGN38; 
A, A’ and D, asterisks) and in the GC (GM130; B, B’ and E, E’); the SG marker IA-2 
(blue, panels C, C’ and F, F’) largely co-localises with Ins (purple) and not with CgB 
(Fig. 1C and C’) in INS1-E cells. In Rin-5AH cells IA-2 appears mostly localised to the 
GC/TGN area, where it co-localises with Ins and CgB (panels F and F’). Arrows 
indicate SGs positive for both Ins and CgB (yellow). Islet cells immunopositive for CgB 
but not for Ins represent non-P cells (panel H). Panel I shows INS1-E cells stained for 
Ins (red) and chromogranin A (CgA). A nearly complete co-localisation of the two 
markers is evident in the GC-TGN area and in the peripheral granules (yellow). Panel L 
shows p-TC3 cells stained for Ins (red) and IA-2/ICA512. Also in this case the co­
localisation between the two markers is large. Panel A was obtained by combining two 
microscopic fields from the same coverslip. Scale bar: 6 pm.
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1.2 Ultrastructural immunohystochemistry o f Ins and CgB
The properties of the SGs in INS1-E cells were further investigated at the ultrastructural 
level. In conventional Epon-embedded cell preparations heterogeneity of the SGs was 
evident, with coexistence of two populations differing from each other in terms of 
electron density of their internal core (Fig. 3 A,B). At the immunoelectron microscopy 
level, however, this difference was no longer visible. The SGs positive for both Ins and 
CgB and those positive for either one of the proteins appeared in fact very similar to 
each other (Fig. 3 C-H).
1.3 The intra-granular distribution o f CgB is a dynamic feature
The next question was whether in INS1-E the dissociation of Ins and CgB is stable or 
may change depending on the functional state o f the cells. For this task we counted the 
SGs at random in at least 25 cell sections of ultrastructurally immunolabelled cells, 
collected after 65 min incubation in resting conditions (KRH containing 2.8 mM 
glucose) or in the same conditions with addition of 5 pM ionomycin (iono) during the 
last 5 minutes and assigned them to one of the following 3 categories: Ins+/CgB', Ins' 
/CgB+ and Ins+/CgB+. In resting cells, over half (66%) of the SGs were positive for Ins 
alone, 27% were mixed and 7% were positive for CgB alone. Ins appeared always 
localised in the granule core, whereas the distribution of CgB varied. In resting cells the 
granin appeared more concentrated in the core (~60%, Fig. 3E and 4A) than at its 
periphery and in the clear halo between the core and the membrane (Fig. 3 D,E,G,H and 
Fig. 4A). Five minutes stimulation with iono failed to induce any change of Ins 
distribution but induced a significant change of that of CgB. The labelling of the CgB
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core dropped to ~30% in favour of the periphery/halo, which approached 70% (Fig. 
4B). Interestingly an intra-SG distribution of CgB similar to that of the iono-stimulated 
cells was found in the cells kept until fixation in the culture medium (Fig. 4C), which 
contains 11 mM glucose and therefore induces some stimulation in the cells.
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Fig. 3 - Conventional and immunoelectron microscopy of INS1-E cells 
immunostaincd for Ins and CgB. Panels A and B show the morphology of different 
types of SG observed by conventional EM: with (solid line) and without (dashed line) 
halo; with dense (°) and light (*) core. The two dense structures on the left lower side in 
panel B could be lysosomes. Panels C-H (scale bars as in H) show different types of 
SGs as revealed by immunolabelling: double-positive for Ins (6 nm colloidal gold 
particles) and for CgB (12 nm colloidal gold particles; D, F, G, H); positive for Ins only 
(C) or for CgB only (E). SGs with different intragranular CgB localisations: in the 
halo+periphery (D, E, F, G and H); in the core (G) and in the entire granule (E). Black 
and open arrows point to some gold particles representing CgB and Ins, respectively. 
Scalebars: 0.1 pm.
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Fig. 4 -  Intra-granular distribution of CgB in INS1-E cells under different 
conditions. Three populations of SGs are illustrated, with CgB labelled in the 
halo+periphery of the core, in the core only, or in both (entire granule). In B the 
ionomycin concentration was 5 pM. Granules counted for each condition were 89 (A), 
90(B) and 165(C).
1.4 Ins and CgB release upon maximal stimulation
Next the secretory behaviour of Ins and CgB under different conditions of stimulation 
was investigated in INS1-E cells, which are well characterised in terms of secretory 
activity 34'. To do this, we had to solve a technical problem connected to the evaluation 
of CgB release. While several ELISA and RIA kits for the detection of rat Ins are 
commercially available, in the case of rat CgB no such kits exist, and it was not even 
possible to devise our own because of the low immunoprecipitation efficiency shown by 
several anti-CgB antibodies available to us. Thus we decided to take advantage of the 
high specificity observed in Western Blot of a monoclonal anti-CgB antibody raised in 
our laboratory (CIRO; Fig. 5). We used this antibody to quantitate CgB in supernatants 
of cells and in aliquots of cell lysates. This method allowed us to concentrate in a single 
spot the entire supernatant volume (500 pi) of each sample replica.
-  74 KDa
55 KDa
Fig. 5 - Specificity of the anti-CgB antibody CIRO. Immunoblotting of INS1-E, Rin- 
5AH cells and a sub-clone derived there-from, Q2. Left panel: the blot was incubated 
with the monoclonal anti-CgB antibody CIRO. Right panel: the blot was incubated with 
a monoclonal anti-tubulin antibody.
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In order to elicit a maximal release, we used a mixture of secretagogues (referred to as 
secretagogue mix, SM) containing 16,7 mM glucose, 1 mM IBMX, 0.1 pM PMA and 
10 pM forskolin. Cells were incubated in the presence of SM for 3, 5 and 20 minutes 
and the protein release was compared to that of cells kept in non-stimulating medium 
(2.8 mM glucose). The results, expressed as percentage (%) of the total Ins and CgB 
content released and as ratio of the % o f Ins and CgB released, are presented in Fig. 6 A. 
The release of both proteins increased gradually at the different time points (Fig. 6A) 
and in parallel as it is also shown in Fig. 6B by the Ins/CgB ratio of nearly 1.1 ± 0.26 at 
5 minutes and 0.99 ± 0.11 at 20 minutes.
The effects of SM were then dissected by applying its components separately from each 
other for 20 minutes. As shown in Fig. 6B, the Ins/CgB ratio upon forskolin stimulation 
resembled that obtained with SM (0.84 ± 0.3). A lower Ins/CgB ratio (0.6 ± 0.12) was 
observed, by converse, with PMA (Fig. 6B), because this secretagogue induced a 
proportionally larger release of CgB than Ins compared to forskolin. A recalculation of 
the release data induced by forskolin and PMA in terms of ratio between the two 
secretagogues (Fig. 6C) revealed that the first is more than 2-fold effective than the 
second in terms of Ins whereas in terms of CgB the difference is of only 1.5-fold.
Ins and CgB release was also evaluated upon high glucose (27 mM) stimulation. This 
condition mobilised the two proteins in a similar way following both 5 and 20 minutes 
incubation (not shown).
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Fig. 6 - Ins and CgB secretion induced by different secretagogues. Panel A: Time- 
course of Ins (dashed line) and CgB (solid line) releases upon stimulation with SM (3, 
5, 20 minutes). Panel B: ratio of Ins versus CgB percentage (%) release, 5 and 20 
minutes following stimulation with SM, forskolin and PMA. Panel C: Ratio of 
forskolin- vs PMA-induced Ins and CgB percentage (%) release.
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1.5 Dissociation o f Ins and CgB release
The release of Ins and CgB was also investigated upon stimulation with the ionophore 
iono, that induces intracellular Ca2+ increase. Keeping in mind the preferential 
mobilisation of CgB to the periphery and halo of SGs observed at the ultrastructural 
level following iono incubation, we asked whether it was possible to detect any 
dissociation in the release of the two proteins.
Indeed, a clear dissociation between Ins and CgB release emerged from the dose- 
dependent responses to iono. CgB release was significant already after 5 minutes of 0.1 
pM iono and increased progressively at higher concentrations (Fig. 7A) reaching a 
plateau, which was however much lower (~1/10) than that induced by SM, at 1 pM 
iono. Ins release was still inappreciable at 1 pM iono; i.e. at the concentration already 
maximal for CgB. Ins was released at the two highest concentrations (5 and 10 pM), 
however at a lower extent than CgB. The differential effect of iono on CgB secretion 
was confirmed after 30 minutes incubation (Fig. 7B). In order to demonstrate that the 
effect of iono on CgB release was Ca2+-dependent, we incubated the cells in the 
presence of the Ca2+ chelator BAPTA and in Ca2+-free medium. In these conditions the 
release of both Ins and CgB was strongly reduced, although not completely blocked (not 
shown).
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Fig. 7 - Dissociation between Ins and CgB release. Panel A: concentration- 
dependence of Ins (dashed line) and CgB (solid line) release induced by 5 minutes of 
ionomycin stimulation. Panel B: time-course of Ins and CgB release induced by 
ionomycin (10 pM).
1. 6 Heterogeneity o f Ins and CgB granules in Rin-5AH cells
The radiation-induced rat Ins-secreting insulinoma Rin-m parental line 342’ 343 and its 
sub-clone Rin-5AH 344, have been widely characterised for their secretory behaviour 345. 
As compared to primary p cells or to a good Ins-secreting model such as INS1-E cells 
RIN-5AH cells show an Ins content which is ~300-fold lower than that of INS1-E (see 
Fig. 14) despite the less significant difference at the mRNA level (see Fig. 26 A-B). 
Rin-5AH cells show a poorer secretion index (S.I.: stimulated/basal release) upon
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exposure to high glucose concentrations 346 as compared to control clones and to 
primary (3 cells. This behaviour has been previously correlated to a low expression of 
Glut-2 347> 348 and to some defects in Ca2+ mobilisation 349 and in nutrient-induced Ins 
release, which so far have been however poorly investigated.
In order to investigate the secretory behaviour of Rin-5 AH in more depth we started to 
characterise these cells in terms of their heterogeneity. Immunofluorescence staining for 
Ins and CgB showed that Rin-5AH are highly heterogeneous with regard to the 
expression and the relative content of the two proteins. Four phenotypes (Fig. 8), 
differently represented among the population, could be identified, which were positive 
for only one of the two SG markers (Ins'/CgB+, 27%; Ins+/CgB", 7%), or showed 
double positive (Ins+/CgB+, 62%) or double negative cells (InsVCgB-, 4%). In the 
double positive cells, as already shown in the section 1 of the Results, Ins and CgB co­
localised largely in the GC and TGN (Fig. 2D-E), and only a partial co-localisation 
could be detected in the SG compartment (Fig. 2D’-E’). This observation led us to the 
following questions: 1) Is the dissociation of Ins and CgB expression in Rin-5 AH cells 
linked to a particular state of the cells, i.e. highly proliferation or stress? 2) Could this 
represent an opportunity to dissect the different subpopulations and to characterise their 
secretory behaviour? 3) Does CgB play a role in p cell secretion? In order to address 
these questions we isolated sub-clones representative of the four subpopulations.
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1.6.1 Rin-5 AH sub-cloning
Sub-cloning of the Rin-5 AH cell line was performed by limiting dilution, i.e. by plating 
cells at a very low density (0.5 cells/well). The first sub-cloning round (384 well at 0.5 
cell/well) yielded 25 clones, that were characterised by immunostaining for Ins and 
CgB. None of them was representative of the InsVCgB' subpopulation. We chose two 
clones, displaying the following characteristics: clone D that was Ins+/CgB', although 
some cells appeared InsVCgB'; the clone Q, that was Ins+/CgB+ but showed an atypical 
accumulation of Ins in the Golgi.
A second sub-cloning round was performed on the D and Q clones and the 30 Q and 32 
D sub-clones were rescreened by means of immunofluorescence staining for Ins and 
CgB. Among the second sub-cloning round we chose the D1 clone, showing low 
signals of both CgB and Ins proteins (Fig. 9 A-C), the D2 clone positive for Ins and 
with barely detectable levels of CgB (Fig. 9 D-F); the Q2 (Fig. 9 G-I) and Q6 (Fig. 9 L- 
N) clones, with prominent Ins and CgB signals accumulated in the GC and few SG at 
the cell periphery.
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Fig. 8 -  Characterisation of Ins and CgB expression in Rin-5AH cells by confocal 
analysis. Note the high heterogeneity of staining for Ins (red) and CgB (green) in the 
cell population. The asterisk indicates a cell devoid of both markers. Scalebar: 6 pm.
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1.6.2 Secretory behaviour o f Rin-5 AH cells and sub-clones
Rin-5 AH cells and the four selected sub-clones were analysed for their Ins and CgB 
content by RIA and immunoblotting, respectively. We confirmed the features observed 
by immunofluorescence, i.e. the low Ins content of D l, the nearly undetectable CgB 
levels in D2, and a high expression of both proteins in Q2 and Q6 (Fig. 10).
Ins release upon various stimuli - The secretory behaviour of the four sub-clones was 
investigated by application of different secretagogues. Regulated secretion was 
triggered by high KC1 and high glucose (KCl/gluc) or by the SM cocktail.
Released Ins was represented as % of total Ins (Fig. 11). In the Rin-5 AH population the 
KCl/gluc stimulus yielded only a 3-fold release, whereas the SM-induced release was 
about 6-fold over basal (Fig. 11 A). The S.I of Rin-5 AH cells is low compared to better 
Ins secreting cell models, such as INS1-E, which have a S.I. as high as 40 (Fig. 14C). 
Ins secretion in Rin-5 AH parental cells could be enhanced by stimulation with 100 pM 
tolbutamide, which causes the closure of the K a t p  channels thus depolarising the plasma 
membrane. Tolbutamide, in synergy with either glucose or SM, enhanced Ins release 
2.1- and 2.5-fold, respectively (not shown).
In contrast to parental cells, the D l sub-clone showed only a little, if any, stimulated 
release (1.5-fold) with both KCl/gluc and SM (1.25-fold) (Fig. 11B). The D2 sub-clone 
(Fig. 11C) displayed a modest stimulated release (3.2-fold with KCl/gluc and 2.5-fold 
with SM, respectively). The Q2 sub-clone showed a release pattern resembling the 
parental population, despite the large Ins accumulation in the GC (Fig. 1 ID) and the low 
number of SG, however its extent was lower upon SM stimulation (2.3-fold; Fig. 1 ID). 
Q6 cells (Fig. 11E) showed a lower regulated Ins release as compared to Q2 cells, 
despite the higher Ins content.
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Fig. 10 -  Ins (A) and CgB (B) content in parental Rin-5AH cells and in the four 
sub-clones. Ins was measured by RIA; the bars represent the average of three 
independent experiments. CgB content, measured by Western Blot quantitation and 
normalisation to tubulin levels, is expressed as percentage of the content in Rin-5 AH 
cells (one representative experiment).
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Fig. 11 -  Secretory behaviour of Rin-5 AH cells and sub-clones. The secretory 
behaviour of Ins in response to gluc/KCl and to the SM is reported. A: Rin-5 AH cells; 
B: D l sub-clone; C: D2 sub-clone; D: Q2 sub-clone; E: Q6 sub-clone. In panel D the 
closed bar represents the basal release after 1 hr incubation with CHX. S.I.: secretion 
index. F: Ins and CgB secretion upon SM stimulation in the five cell types analysed. 
The CgB release of D2 sub-clone is discussed in the text. The results are expressed as 
S.I. All the experiments in Fig. 11 were performed three times with triplicate samples 
and the average of results is represented.
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Regulated versus constitutive Ins secretion - Having observed a low SI for Ins in the 
Rin-5 AH derived sub-clones, and particularly in the case of Q2 cells a high value of 
basal Ins secretion, we investigated the contribution of the constitutive secretory 
pathway in Ins release of Rin-5 AH and derived subclones.
To evaluate this for the different sub-clones, parallel experiments were carried out 
where cells were kept for 1 hour in the presence of the protein synthesis inhibitor 
cycloheximide (CHX), and then stimulated for release in the presence of CHX. This 
procedure, which allows for the release of proteins from the constitutive pathway 
without altering the SGs accumulating within cells in the absence of a stimulus 
triggering regulated release, has been previously used to discriminate bona fide 
regulated secretion from constitutive one 98. Following 1 hour CHX treatment the 
release pattern of Rin-5 AH cells and all clones, but one, namely Q2, did not change, 
indicating the prevalence of a regulated release pathway in the parental population. 
Interestingly, the basal Ins release of Q2 cells decreased following CHX treatment, 
suggesting that in these cells a fraction of Ins is released by a constitutive pathway. (Fig. 
1 ID; black bar).
Basal Ins release from Q6 cells was higher than in the other sub-clones, but it was not 
affected by CHX, thus excluding the contribution of constitutive secretion and 
suggesting that Ins SGs in these cells may have a ‘disregulated’ discharge.
CgB release -  CgB release was measured in Rin-5 AH cells and sub-clones under basal 
condition and following application of SM. As previously described this was performed 
by a dot blot method and the SI of CgB was compared to that of Ins in the different 
clones (Fig. 1 IF). Following maximal stimulation with SM, parental Rin-5 AH cells as
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well as D l, D2 and Q2 sub-clones displayed similar CgB SI (Fig. 11F). The Q6 sub­
clone instead showed a higher efficiency of CgB release. The secretory behaviour of 
CgB was independent of the protein content (compare Fig. 10B with Fig. 1 IF). 
Compared to the Ins release, that of CgB appeared not parallel in the different sub­
clones. In particular, sub-clones Q2 and Q6, which have the highest levels of CgB, 
showed different SI for it (Fig 1 IF) with respect to Ins, Q6 displaying a S.I. lower than 
the parental population despite the highest CgB content. The CgB S.I. in the D2 sub­
clone, apparently comparable to that of parental population and other sub-clones, can be 
explained by the method of data normalisation. In fact, expressing the protein release as 
% of the total content in the case of the D2 sub-clone, whose CgB content is very low, 
leads to over-estimate the S.I. In terms of optical density (OD) measured at the 
densitometer, CgB released in the media was not significantly higher than in control 
cells, whereas in the other cell types CgB levels in the media were much higher (not 
shown).
1.6.3 Biochemical characterisation o f regulated secretory markers
Since regulated secretion relies on a complex molecular machinery, we asked about the 
expression of some pivotal proteins involved in this process. The four Rin-5AH sub­
clones were investigated by immunoblotting for their levels of the granule luminal 
protein CgA, for dopamine-p-hydroxylase (DBH) and for proteins involved in regulated 
exocytosis: VAMP2/synaptobrevin2, SNAP-23 and SNAP-25, Munc 18-1,
synaptotagmin I, syntaxin 1 (Stx) and synaptophysin I (SYP). Among the sub-clones 
only D2 showed reduced levels of VAMP2 and SYP (Table 1). The levels of the other
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proteins analysed were similar in all the sub-clones as compared to parental cells. From 
these data it is not possible to draw a correlation between the expression of the 
exocytotic molecular machinery proteins and the poor secretory performance of Rin- 
5AH sub-clones.
Rin-5AH Dl D2 Q2 Q6
Synaptotagmin I + + +/- + +
Munc-18 + + + + +
DBH + + + + +
Stx I + + + + +
SNAP-25 + + + + +
SNAP-23 + + + + +
CgA + + +/- + +
VAMP2 + +/- +/- + +
SYP + + +/- + +
Table 1 -  Western Blot analysis of proteins involved in regulated secretion in Rin- 
5AH cells and in the various sub-clones. The markers of regulated secretion reported 
in the table were investigated. + indicates presence; - indicates absence; +/- indicates a 
low expression
1.6.4 Dissection o f the Ins secretory pathway in RIN-5 AH and sub-clones
We decided to investigate two key steps of the Ins secretion pathway in Rin-5 AH cells 
and sub-clones: the intracellular Ca2+ mobilisation and the mitochondrial ATP 
production upon secretagogue stimulation.
Ca2+ mobilisation -  We measured the overall intracellular Ca2+ mobilisation in Rin- 
5AH cells and in the four sub-clones by loading adherent cells with the Ca2+ indicator
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Fura2/AM, followed by population analysis at the fluorometer. Fura2/AM emits at two 
different wavelengths, depending on whether it binds (340 nm) or not to Ca2+ (380 nm). 
Thus, an increase in the whole free Ca2+ concentration leads to an increase in the bound 
signal (340 nm) and to a parallel decrease of the unbound signal (380 nm), which allows 
for a ratiometric measurement of Ca2+ mobilisation (expressed as 340nm/380nm ratio). 
The results of the fluorometric analysis of one representative experiment are expressed 
as % increase over basal in Fig. 12. The Ca2+ mobilisation induced by carbachol (cch) 
was used as a positive control for the analysis. The comparison of SM- and cch-induced
04- •Ca mobilisation showed that D l and D2 sub-clones respond similarly, whereas Rin- 
5AH cells and Q2 sub-clone mobilised more Ca2+ upon cch and Q6 displayed the 
opposite behaviour. From these data we conclude that Rin-5 AH cells and the four 
clones derived therefrom are competent for Ca2+ mobilisation; however, the extent of 
such mobilisation is independent of their secretory efficiency (compare Fig. 12 with 
Fig. 1 IF).
s
Uin-SAII Dl D2
Fig. 12 - Fluorometric analysis of intracellular Ca2+ mobilisation. The cell 
populations were stimulated with carbachol (cch, black lines) or SM (blue lines). On the 
Y-axis the % of Fura-2/AM fluorescence increase over basal is represented. The figure 
shows the results of one representative experiment carried on the cell populations.
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ATP production -  Mitochondrial nutrient metabolism is coupled to ATP synthesis by 
the ETC and driven by the A'Fm. ATP production starts as soon as 2 minutes following 
stimulation of Ins secretion and lasts few more minutes 255. We measured the total 
intracellular ATP level 4 minutes following stimulation by means of a luminescent 
assay that detects ATP and ADP in cell lysates. While Rin-5AH cells produced ATP 
upon stimulation of Ins secretion, the four sub-clones appeared unable to produce ATP, 
rather the overall ATP levels decreased following stimulation. ADP levels (not shown) 
decreased in parental cells, whereas in the four sub-clones they increased, leading to the 
ATP:ADP ratio shown in Fig. 13. The average increase of the ATP:ADP ratio over 
basal, obtained from three independent experiments, is reported. Since the detection 
method employed was not quantitative, we can not conclude that the apparently higher 
ATP levels observed at basal conditions in the four sub-clones compared to Rin-5 AH 
cells are a bona fide observation.
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Fig. 13 - ATP levels measured in cell lysates under basal and stimulated conditions.
The changes in ATP: ADP ratio upon SM application in parental Rin-5 AH cells and sub­
clones are expressed as % of luminescence over basal. Only parental cells are able to 
increase the ATP:ADP ratio upon stimulation, whereas the four sub-clones display a 
decrease of ATP: ADP.
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2. Molecular mechanisms of the impaired Ins secretion in RIN-5AH cells
The sub-cloning strategy described in the previous section led us to consider Rin-5 AH 
cells and the sub-clones derived therefrom as a valuable tool to investigate novel 
mechanisms underlying their low efficiency of Ins secretion. Despite their low S.I., Rin 
cells have been used by many research groups as a p cell model to study the regulation 
of Ins secretion ' . Instead, their poor secretory behaviour was never correlated to a
pathological state of p cells, and the molecular mechanisms underlying the latter have 
not been investigated in depth. We decided to look into the mechanism(s) responsible 
for the impairment of Ins secretion in Rin-5AH cells and as a more homogeneous 
model, the previously described Q2 sub-clone. We selected this sub-clone because as 
compared to the Rin-5AH parental population it showed a higher CgB content but a 
similar S.I., and a lower Ins S.I. despite the comparable protein content. In addition, a 
fraction of its basal Ins release could be ascribed to constitutive secretion (paragraph
1.6.2 of Results). As a reference model of good-functioning p cell we used the 
previously described INS1-E cell line.
2.1 Comparison o f Ins content and S.I. in INS1-E and Rin-5 AH insulinomas
The rat insulinoma cell line INS1-E, as compared to Rin-5 AH and the Q2 sub-clone 
derived therof, greatly differs in the Ins content and in the secretory efficiency. Ins 
contents measured by both RIA and ELISA (Fig. 14A) showed what was already known 
from the literature, but never analysed comparatively, i.e. that Rin-5AH and Q2 cells 
have approximately 300 times less Ins than INS1-E cells. The secretory behaviour of 
the three cell types, upon stimulation of Ins secretion for 20 minutes with SM, is
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represented in Fig. 14B expressed as percentage of total content and in Fig. 14C as S.I. 
INS1-E release around 12% of their Ins content upon stimulation, whereas the basal 
release is as low as 0.2%; Rin-5 AH and Q2, despite a 300-fold lower Ins content than 
INS1-E cells, show a similar % of stimulated release (14% and 9.6%, respectively), 
however their basal release is significantly higher (3.7% and 4.1%, respectively). In 
terms of S.I. (Fig. 14C), INS1-E are very efficient (S.I.=40), whereas Rin-5 AH and Q2 
cells respond 10- to 20-fold less (S.I.=4 for Rin-5 AH and S.I.=2 for Q2).
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Fig. 14 -  Ins content and secretory behaviour of INSI-E, Rin-5AH and Q2 sub­
clone derived therefrom. A: Ins concentration is indicated as ng Ins/mg total protein 
content. The Y-axis reports values on a logarithmic scale. B: Ins release of INSI-E, Rin- 
5AH and Q2 cells. Open bars: basal conditions (C); closed bars: SM stimulation. The 
results were expressed as % of released Ins/total content. C: Ins secretion expressed as 
stimulation index, i.e. stimulated/basal.
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2.2 Comparison o f cytosolic Ca2+-mobilisation and ATP production in Rin-5 AH  
and Q2 with INSI-E
2.2.1 Cytosolic Ca2+ measurements
The stimulation of Ins secretion determines a net Ca2+ influx through the voltage-gated 
Ca2+-channels, accompanied by a mobilisation of Ca2+ from intracellular stores, such as 
ER and mitochondria. The intracellular Ca2+ homeostasis, i.e. the equilibrium between 
free and bound cytosolic Ca2+ and sequestered Ca2+, is maintained by the cross-talk 
between ER and mitochondria. We investigated whether a defect in Ca2+ mobilisation 
correlated with the poor secretory phenotype of Rin-5 AH and Q2 cells as compared to 
INSI-E. The overall Ca2+ mobilisation was detected by single-cell imaging of 
Fura2/AM-labelled cells at the fluorescence microscope. For each cell type about 50 
cells for each coverslip were analysed. The resulting traces were averaged and 
represented in Fig. 15. Upon stimulation with SM INSI-E cells show a sharp Ca2+ peak 
with mean height of ratio 340nm/380nm of 0.5 (Fig. 15A). The extent of Ca2+ 
mobilisation in Rin-5 AH was variable (not shown) and lower than that in INSI-E; Q2 
cells (Fig. 15B) showed a much smaller peak as compared to INSI-E.
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Fig, 15 -  Ca2+
mobilisation measured 
by single cell imaging, 
Fura2/AM fluorescence 
measured in INS1-E (A) 
and Q2 (B) cells was 
normalised by calculating 
the dF/F ratio (see text). 
The graphs depict the 
average of several cells 
(14 for INS1-E and 8 for 
Q2). The arrows indicate 
SM administration.
Scalebar: 50 seconds.
2.2.2 ATP production
We measured ATP production in INS1-E, Rin-5AH and Q2 cells in unstimulated 
conditions and 4 minutes following application of SM. INS1-E cells showed an 
increase in the ATP:ADP ratio of 26% upon stimulation as compared to the basal 
condition, which was set as 100%. Rin-5AH showed a smaller increase of the 
ATP:ADP ratio (19%), whereas Q2 cells showed a 35% drop in the ATP:ADP ratio 
upon stimulation of secretion (Fig. 16A).
An impaired ATP production has been shown in cell models over-expressing the 
mitochondrial protein UCP2 (see Introduction, section 2.2 and 2.4); we therefore 
evaluated UCP2 protein levels in the three investigated cell models by Western blotting. 
The results obtained from the quantitations of two independent experiments have been 
normalised to tubulin levels and averages are shown in Fig. 16B. Q2 cells express a 
higher (~2.6-fold) amount of UCP2 as compared to both INS1-E and Rin-5AH. We
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conclude therefore that one of the possible causes of the lower ATP production in Q2 
cells is the over-expression of UCP2.
Fig, 1 6 -  ATP and UCP2 levels 
in the three cell models 
investigated. A ATP levels were 
measured in cell lysates of INS1- 
E, Rin-5AH and Q2 cells 
following incubation at resting 
conditions (C; open bars) or with 
SM (closed bars) B: UCP2 levels 
in INS1-E, Rin-SAH and Q2 
cells. Lett; one representative 
Western Blot is shown. Upper 
part: the blot was incubated with 
a polyclonal anti-UC’P2 antibody; 
lower part: the same blot was 
incubated with a monoclonal 
anti-tubulin antibody. Right: The 
CD of UCP2 were normalised 
with tubulin levels. The graph 
represents the average of two 
experiment.
2.3 Mitochondrial membrane potential
Since Rin-5AH cells appear to have an intermediate phenotype between INS1-E and Q2
9 4-cells both in terms of ATP production and Ca mobilisation upon secretion stimulation, 
we decided to focus our attention on the comparison between INS1-E and Q2 for the 
following studies. The impaired production of ATP upon stimulation of secretion in the 
Q2 sub-clone, in combination with the observed lower cytosolic Ca2+ mobilisation led 
us to hypothesise that these cells might have an impairment of mitochondrial function. 
To evaluate this hypothesis the A\|/m was measured by the fluorescent dye TMRM, 
which emits fluorescence proportionally to the A\|/m. When analysed under the
-*-55 KIM
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fluorescence microscope Q2 cells (Fig. 17E) showed a very low A\|/m as compared to 
INS1-E (Fig. 17A). The fluorescence intensity was analysed in the population of INS1- 
E (160 cells) and Q2 (100 cells ), using for each cell type the data of three independent 
experiments. The arbitrary fluorescence intensities of single cells from the different 
populations were grouped into four intervals: 1 (a.u. 0-4,999), 2 (a.u. 5,000-9,999), 3 
(a.u. 10,000-14,500) and 4 (a.u. above 15,000). INS1-E cells showed a population 
distribution with the majority of cells (92.5%) falling into fluorescence intervals 2 and 3 
and a residual 7.5% in interval 4 (Fig. 17B), whereas Q2 showed the majority of cells 
(93.1%) falling in intervals 1 and 2 and residual 5.9% and 1% in intervals 3 and 4, 
respectively (Fig. 17F).
2.4 Mitochondrial morphology
Mitochondrial dysfunctions are often associated to an altered morphology. Therefore 
the mitochondrial morphology was analysed in vivo by staining cells with the 
appropriate concentration of MitoTracker (25 nM for INS1-E, 50 nM for Q2) and 
observed under the Deltavision system. The acquired images were subjected to 
deconvolution and three-dimensional reconstruction, as already described. INS1-E cells 
showed a filamentous-like mitochondrial morphology (Fig. 17C), which is consistent to 
previous observations 255. In contrast, in Q2 cells (Fig. 17G) mitochondria appeared 
highly fragmented and swollen. We confirmed the latter observation by conventional 
electron microscopy, where in INS1-E (Fig. 17D) mitochondria appeared tubular, 
whereas in Q2 cells (Fig. 17H) they are swollen and round-shaped.
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2.5 Functional analysis o f AWm
The observations obtained so far showed that Q2 cells have an impaired ATP 
production upon stimulation of secretion and a distinctly lower A\|/m than INS1-E. Both 
these two features have been observed in cells exposed to an oxidative stress condition 
255. Under this condition mitochondria of (3 cells are not able anymore to increase their 
A\|/m upon stimulation of Ins secretion. We investigated this issue by loading the cells 
with TMRM and performed a time-lapse recording at the confocal microscope under 
basal condition and upon SM application. The A\|/m values, originally indicated by 
arbitrary units of fluorescence, were normalised by calculating the dF/F ratio (Fig. 18A- 
B). The mean increase of TMRM fluorescence over basal in INS1-E and Q2 cells is also 
represented in Fig. 18C. While in INS1-E cells (Fig.l8A) there is a marked increase of 
A\|/m short after SM administration, in Q2 cells (Fig.l8B) instead the increase has a 
different kinetic and is smaller. In the set of experiments presented here we used SM as 
stimulus, however we obtained similar results also by administration of high glucose 
(27 mM; not shown). At the end of the experiment we added the mitochondrial 
uncoupler FCCP, which decreases TMRM fluorescence. The decrease of fluorescence 
induced by FCCP obtained from 3 independent experiments was measured and plotted 
in Fig.l8D. It is known that the higher the A\|/m, the larger and faster its decrease upon 
uncoupling. The TMRM fluorescence of INS1-E cells falls steeply in the first 100 
seconds of uncoupling, whereas the decrease in Q2 cells appears slower and less 
pronounced.
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Fig. 18 -  A, B: Functional analysis of A\i/m by TMRM staining and time-lapse 
recording. A: INS1-E cells; B: Q2 cells. The graphs show the average of around 10 
cells from one representative experiment; The values of TMRM fluorescence were 
normalised by calculating the dF/F ratio. SM was added at 60 seconds; FCCP at 1300 
seconds. Scalebar: 500 seconds. There is a marked difference between INS1-E and Q2 
in the kinetics of the A\pm (TMRM fluorescence) increase following stimulation o f Ins 
secretion with SM. C: The A\|/m increase upon SM stimulation was represented as 
average of the peak/basal ratios ± s.e.m. D: A\j/m decrease 100 seconds after application 
of the mitochondrial uncoupler FCCP. The results, obtained from three independent 
experiments, were expressed as average of the ratio between fluorescence values at t=0 
and t= 100 seconds.
2.6 Attempts to rescue the A Wm response in Q2 cells
CGP-37157 treatment - We hypothesised that the poor cytosolic Ca2+ mobilisation 
observed in Q2 cells might account at least partly for the impaired mitochondrial 
functionality, first of all because of the impaired ATP production and also because the
'2*4-Ca cross-talk between ER and mitochondria plays a crucial role in the mitochondrial
2 j
Ca homeostasis and mitochondrial functionality. Several efforts were made in order to
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visualise the mitochondrial Ca2+ by transfecting cells with aequorin targeted to the 
mitochondria and, alternatively, by using the indicator Rhodl/AM, that has high affinity 
for mitochondria. However, Q2 cells showed very low transfection efficiencies, not 
allowing for a population analysis with aequorin, and Rhodl/AM displayed a low 
selectivity for mitochondria, especially in INS1-E cells, which resulted in recording 
fluorescence both from the cytosolic and the mitochondrial compartments. We therefore 
decided to test the role of Ca2+ in the mitochondria indirectly, by blocking the Ca2+ 
export and consequently increasing the Ca2+ levels inside the mitochondria. The only 
system that has been characterised at the molecular level, which is relevant to the 
mitochondrial Ca2+ export, is the Na+-Ca2+-exchanger, that is favoured by the A\|/m and 
can be inhibited by the derivatives of diltiazem, such as CGP-37157. We argued that if 
on one side mitochondrial Ca2+ levels in Q2 cells are possibly lower, inhibition of Ca2+ 
export 232 could improve both the A\pm response and possibly the secretory behaviour. 
Since in a good cell model such as INS1-E the effect of CGP-37157 has been already 
characterised 354 and it is known that upon maximal stimulation (30 mM glucose) there 
is no further increase of Ins secretion, we performed all the analysis only on Q2 cells. 
The latter were pre-incubated for 4 minutes with CGP-37157, which was kept during 
the following 20 minutes incubation in basal conditions. Both the A\|/m and Ins secretion 
were measured under these conditions. Upon CGP-37157 addition the A\|/m of Q2 cells 
gradually increased and remained sustained over at least 10 minutes (Fig. 19). At the 
secretory level, this resulted into a -36%  improvement o f Ins secretion (not shown). 
This result was confirmed in three independent experiments, where the % increase of 
Ins secretion in the cells treated with CGP-37157 was similar; however, due to some 
variability in the cells, it was not possible to mediate the results.
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Fig. 19 -  Effects of CGP-37157 on A\|/m and Ins secretion in Q2 cells. Analysis of 
A\|/m by TMRM staining and time-lapse recording of cells treated with CGP-37157. The 
results were normalised and expressed as dF/F. CGP-37157 was added at 30 seconds. 
Scalebar: 200 seconds. The TMRM fluorescence was monitored for 1000 seconds, until 
the signal decreased to basal values.
Antioxidant treatment - The data so far obtained all suggest that Q2 cells could be cells 
in a state of chronic oxidative stress. We decided therefore to treat the cells overnight 
with ascorbic acid, that is not specific for mitochondria nor especially powerful as an 
antioxidant, however it clearly acts in ROS scavenging 355. After incubation, the 
antioxidant was kept in the medium and measurements of A\|/m and of Ins secretion at 
resting and stimulated conditions were performed. While Ins release was not improved 
by the antioxidant treatment (not shown), we observed some changes in the A\|/m. The 
mitochondrial response to stimulation remained unchanged (not shown), however the 
distribution of A\|/m showed a clear shift, with more cells in the highest ranges of values 
(Fig. 20). We therefore conclude that an oxidative stress condition may well be at the 
basis of the phenotype of Q2 cells, and a more specific and powerful antioxidant might 
be able to rescue to a greater extent the defective secretory behaviour of Q2 cells.
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Fig. 20 -  Effects of ascorbate on A\j/m in Q2 cells. Distribution of mitochondrial 
potential in Q2 cells (A) and in Q2 cells treated overnight with ascorbic acid (B). The 
A\|/m intervals are the same than in Fig. 10A. A shift of A\|/m toward the highest values 
can be observed.
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3. Ins and CgB secretion under ER stress conditions
The ER stress has been in recent years more and more implicated in diabetes and P cell 
dysfunction ’ . A correlation between ER and oxidative stress has been described
a q i OQO
, although it is not clear yet how they are causally linked to each other. The results 
presented in the previous section suggest that the Q2 cell model appears to bear a state 
of oxidative stress. Independently of the causative mechanism, we asked whether it 
might be accompanied by, or make cells more susceptible to, ER stress. In addition, the 
observed peculiar accumulation of Ins in the Golgi area suggested that the protein might 
undergo incomplete maturation, thus generating a stressful condition for the cell.
We compared Q2 cells to INS1-E, and addressed the following questions:
• Does a cell model carrying oxidative stress (Q2) appear more sensitive to ER
stress induction in terms of cell functionality and apoptosis?
• What is the effect of ER stress at the level of granule proteins other than Ins?
Bona fide ER stress was induced by treatment of cells for 24 hours with thapsigargin 
(Tg), an inhibitor of the ER Ca2+ pump SERCA 2b, which determines an increase in 
unfolded proteins and thus induces ER stress 356. This type of treatment represents a 
maximal stress condition, which is accompanied by apoptotic cell death and by the up- 
regulation of the expression of several ER stress markers (see Introduction, section 1.3), 
including:
- BIP, which acts as the upstream regulator of the three ER stress signal transducers 
IRE1, PERK and ATF6;
- ATF4, whose expression is induced upon PERK activation;
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- CHOP, which is induced by both PERK and ATF6 through the ATF4 pathway;
- XBP-1, which upon alternative splicing by IRE1 generates a functional transcription 
factor. In the case of XBP-1, following quantification of the two splicing forms the ratio 
of the spliced XBP-1 versus the unspliced was calculated. The alternative splicing was 
revealed by enzymatic digestion of the PCR product with Pst I.
The above markers were analysed by semiquantitative PCR to monitor the induction of 
ER stress. In addition cell death by apoptosis was assessed by propidium iodide (PI) 
staining of fixed cells and flow cytometric analysis.
To test the effects of ER stress on Ins secretion and on the regulated secretory granule 
machinery we chose to analyse a sub-lethal stress condition, in which no significant 
signs of cell death are detectable in the cell population. In our cell models the sub-lethal 
stress inducing treatment consisted of 6 hours incubation with 3 pm Tg.
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3.1 Expression o f ER stress markers in basal conditions
The semiquantitative analysis performed in basal conditions showed that the only 
markers of ER stress that were differently expressed in INS1-E and Q2 cells are BIP 
(Fig. 21 A) and XBP-1 (Fig. 2 IB). BIP levels were approximately 4-fold higher in 
INS1-E as compared to Q2 cells; in contrast, in the latter cell models the spliced product 
of XBP-1 was 1.6-fold more expressed than in INS1-E cells.
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Fig. 21 -  Basal levels of ER stress m arkers in IN Sl-E and Q2 cells. Semiquantitative 
PCR analysis of expression levels of some markers of ER stress measured in cells kept 
at rest. A: Expression levels of BIP, ATF4, CHOP in INSl-E and Q2 cells. INSl-E 
show higher level of BIP than Q2. B: Under ER stress conditions, XBP-1 mRNA 
undergoes splicing. Q2 cells display higher levels of the XBP-1 spliced form.
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3.2 Maximal induction o f ER stress
3.2.1 Expression o f ER stress markers
The quantitation of PCR products obtained following semiquantitative amplification 
were normalised for GAPDH levels in control conditions and upon 24 hours o f Tg 
treatment (Fig. 22). In terms of fold increase, i.e. the ratio between Tg treated and 
control conditions, BIP mRNA levels (Fig. 22A) increased 4.6-fold in INSl-E and 3.5- 
fold in Q2 cells. The increase of ATF4 levels (Fig. 22B) is similar in the two cell types 
(3-fold in INSl-E and 3.3-fold in Q2). Also the induction of CHOP (Fig. 22C), is not 
significantly different (3.7-fold in INSl-E, 3.9-fold in Q2).
Marked differences were observed with regard to the induction o f XBP-1 splicing upon 
Tg treatment (Fig. 22D). The spliced transcript was induced 9-fold in INSl-E cells, 
whereas in Q2 cells its increase was lower (4.3-fold).
3.2.2 Expression levels o f Ins
Rat cells, as well as mouse cells, transcribe Ins from two non allelic genes, Insl and 
Ins2. Insl is the most abundant transcript in INSl-E cells, whereas in Rin-5AH and Q2 
cells derived therefrom it is the only transcript detectable 357. In Tg-treated INSl-E cells 
the Insl mRNA levels decreased 10-fold (Fig. 23 B,C) and the Ins2 was no longer 
detectable (Fig. 23 A,C). In Q2 cells Tg treatment caused a 6-fold decrease in Insl 
transcript levels (Fig. 23 B,C).
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Fig. 22 -  Induction of ER stress m arkers following 24 hours Tg. Expression levels 
of BIP (A), ATF4 (B), CHOP (C) and of the spliced form of XBP-1 (D) in control 
INSl-E and Q2 cells and after 24 hours Tg. XBP-1 splicing causes the loss of a Pst I  
restriction site, therefore the PCR product is a 600bp band, whereas the unspliced form 
gives two bands of 300bp. On the left the PCR panels for each marker are shown; on the 
right the graphs derived there-from are depicted. Open bars: control conditions (C); 
closed bars: Tg. The Secretion Index (S.I.) of each marker over basal levels is reported 
in the graphs. Each experiment was performed three times in duplicate.
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Fig. 23 -  Effects of ER stress induction on Insl and Ins2 gene. Expression levels of 
Insl (B, C) and Ins2 (A, C) in INSl-E and Q2 cells in control conditions and after 24 
hours Tg. Q2, as well as parental cells, express only Insl. Open bars: control conditions 
(C); closed bars: Tg.
3.2.3. Cell death by apoptosis
The % of apoptotic cells induced by 24 hours of Tg treatment in INSl-E and Q2 was 
measured by flow cytometry analysis following PI staining of fixed cells. The results 
are represented in Fig. 24, where for each cell type the DNA content (DNA) was 
measured (DNA <2n indicates apoptotic cells; DNA =2n represents the % of cells in Gi 
phase; DNA >2n represents actively replicating cells).
In both INSl-E (Fig. 24A) and Q2 cells (Fig. 24B) in control conditions the fraction of 
apoptotic cells (DNA <2n) was in the range of 10% . Upon 24 hours incubation with 
Tg, the population of apoptotic cells in the three lines increased about 5-fold, reaching 
50% in INSl-E and 40% in Q2 cells. The fraction of cells replicating (i.e., DNA >2n)
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was similar in INSl-E (40%) and Q2 (49%) and decreased upon 24 hours of stress 
induction in both cell models.
24li TjControl Control 6li Tg
Fig. 24 -  Analysis of apoptosis in INSl-E and Q2 cells after 6 and 24 hours 
incubation with Tg. C: Control conditions. DNA <2n: apoptosis; DNA =2n; Gi phase; 
DNA >2n: replication.
3.3 Sub-lethal induction o f ER stress
3.3.1 Analysis o f induction o f apoptosis
Once determined the effects of a massive stress in our cell models, we identified a sub- 
lethal condition, in which some ER stress markers were induced with no visible cell 
death. Our aim was to mimic a condition of ER stress, in which to analyse 
compensatory or detrimental effects on the regulated secretory pathway.
Following 6 hours of Tg treatment there was no significant induction of apoptosis in our 
reference model (INSl-E cells) as compared to untreated cells (Fig. 24A). Interestingly, 
under these conditions we observed that Q2 cells appeared more susceptible to 
apoptosis (the % of apoptotic cells increased from 12.4±3.6 to 24±8.3; Fig. 24B).
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Moreover, while in INSl-E cells the fraction of replicating cells was not affected by 6 
hours Tg treatment, Q2 cells showed a marked decrease in the size of the population of 
replicating cells (from 50% in controls to 25% upon 6 hours Tg).
3.3.2 Analysis o f ER stress markers expression
The expression analysis of the ER stress markers after 6 hours Tg treatment showed 
increased levels of BIP mRNA (3-fold) in INSl-E and Q2 cells (Fig.25A). The 
expression of ATF4 (Fig. 25B) showed no change in INSl-E, whereas in Q2 it was 3- 
fold higher. CHOP (Fig. 25C) was up-regulated in INSl-E and Q2 to a similar extent 
(3- and 5-fold, respectively. The increase of XBP-1 splicing was higher in INSl-E cells 
(5.5-fold) than in Q2 (3.5-fold; Fig. 25D).
80
328bp
C ap d h
T-j C J j
IN S l-E  Q2
□ ( f>h 
■  1 «• <>li
J RI71
 n = m _____
IN M -E Q2
25<H>p
G apdh
IN S l-E  q :
i-
■
IN SI-E  i)2
I25bp
(.ap tlh
<C I-* C 'g
IN Sl-E  V 2 : u J
IN S l-E  (,)2
C T g  C J j L
IN SI-E  9 2
Pst I + + + +
Z  IIMfl I s.I, I | S.1 3.5 I
.k I a. 801
/
I 60 JJ
IN S l-E  Q2
Fig. 25 - Induction of ER stress markers following 6 hours Tg. Expression levels of 
BIP (A), ATF4 (B), CHOP (C) and of the spliced form of XBP-1 (D) in control INSl-E 
and Q2 cells and after 6 hours Tg. Open bars: control conditions (C); closed bars: Tg.
Summarising the results of the present section, after 6 hours of Tg treatment the 
expression of some ER stress markers (BIP, ATF4, CHOP) was similar to that obtained 
following 24 hours treatment, although some differences were observed: in Q2 cells BIP 
was already over-expressed following 6 hours of Tg at the same level than after 24 
hours; ATF4 was not induced in INSl-E cells after 6 hours of Tg; the spliced XBP-1 
form was less induced following 6 hours Tg than after 24 hours, however also in this 
case in Q2 cells its level did not further increase after 24 hours Tg.
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3.3.3 Expression analysis o f granule markers upon sub-lethal stress induction
The following granule markers were chosen to be analysed under sub-lethal stress 
conditions:
- Insl and Ins2 
-CgA
- CgB
- IA2/ICA 512
- SNAP-25 
-SYP.
Insl (Fig. 26B) and particularly Ins2 (Fig. 26A) mRNA levels markedly decreased 
(-30% and -80%  over untreated cells, respectively) in INSl-E cells following 6 hours 
Tg treatment. In Q2 cells the stress-induced decrease of Insl was similar as in INSl-E 
cells. CgA and CgB levels (Fig. 26 C,D, respectively) did not change in INSl-E cells 
treated with Tg, whereas in Q2 we could observe a slight increase of CgA and CgB 
mRNA (around 2- and 1.5-fold, respectively). Similar results were observed in the case 
of IA-2/ICA 512 (Fig. 27A) and SNAP-25 (Fig. 27C). SYP levels (Fig. 27B) were not 
affected by Tg treatment.
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Fig. 26 - Effects of ER stress induction on the mRNA levels of some granule 
markers I. Expression levels of Insl (B) and Ins2 (A), CgA (C) and CgB (D) in control 
INSl-E and Q2 cells and after 6 hours Tg. Open bars: control conditions (C); closed 
bars: Tg.
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Fig. 27 - Effects of ER stress induction on the mRNA levels of some granule 
markers II. Expression levels of ICA512/IA-2 (A), SYP (B) and SNAP25 (C) in 
control INSl-E and Q2 cells and after 6 hours Tg. Open bars: control conditions (C); 
closed bars: Tg.
3.3.4 Ins and CgB secretion under sub-lethal stress conditions
Ins and CgB release from INSl-E and Q2 cells upon sub-lethal stress conditions was 
evaluated by stimulation with SM. The results of the Ins secretion assays are 
represented in Fig. 28. Tg-treated INSl-E cells showed no difference in the stimulated 
Ins release as compared to control cells, however the basal release of Ins increased 2- 
fold (Fig. 28A). Tg-treated Q2 cells showed a 2-fold increase of basal Ins release, but 
also showed a 2-fold decrease of the stimulated release (Fig. 28B). Their S.I. well 
reflects this change with a 4-fold decrease.
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Preliminary analysis of CgB secretion showed no effect of 6 hours Tg treatment in both 
INSl-E and Q2 cells (not shown).
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Fig. 28 - Effects of ER stress induction on Ins secretion. Ins secretion was measured 
in INSl-E (A) and Q2 (B) cells in control conditions and after 6 hours Tg. C (resting 
conditions): open bars; SM: closed bars. The results are expressed as % of Ins total 
content and the S.I. is reported in the graphs.
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1. Ins and CgB granules in ft cell models
Multiple secretory proteins are co-expressed by specialized cells and transported along 
the secretory pathway. Their transport is often envisaged as the flow of a protein 
mixture from the ER to the GC and then to the SGs, destined to be finally discharged to 
the extracellular space upon appropriate stimulation 13. However, in various cell types 
the secretory proteins flowing out of the Golgi do not remain intermixed but are sorted 
to different types of SGs, some of which contain single proteins or mixtures of a few 77, 
79, 358. In Ins-secreting cells separate sorting had never been reported previously. The 
various secretory proteins, including granins, were rather believed to be co-stored and 
co-released with Ins 68'70. Our data, obtained in four different Ins-secreting cell types, 
show that indeed in the GC/TGN area the hormone and CgB are probably intermixed. In 
the SGs, however, co-storage of Ins and CgB is restricted to only a fraction of the 
organelles. The other SGs appear in contrast specific for only one of these two secretion 
products. The discrepancy of our results with respect to the previous conclusions is 
probably due, at least in part, to the different experimental techniques used. In fact, 
dissociation between Ins and CgB, which was barely visible in our conventional 
confocal images, became evident when cells were analysed by the Deltavision™ 
reconstitution system, and was confirmed by electron microscopy. The multiplicity of
86
the SGs observed with regard to Ins and CgB may reflect only part of that existing in 
the Ins-secreting cells. In fact, other secretory proteins are expressed along with Ins in p 
cells 70'72. Additional proteins travelling along the secretory pathway might have the 
tendency to segregate away from Ins and possibly also from CgB, contributing to an 
even more complex SG pattern. This however does not seem to be the case for the other 
granin, CgA, that in the SGs of P-TC3 and INSl-E cells largely co-localised with Ins.
In the context of the observed dissociation between Ins- and CgB- containing SGs, an 
unexpected result revealed by ultrastructural immunocytochemistry was the intra- 
granular redistribution of CgB from the core to the halo, taking place when INSl-E cells 
kept at rest were treated for a few minutes with iono. The redistribution to the halo may 
be typical of stimulated cells since it is present also in INSl-E kept in the culture 
medium, which contains 11 mM glucose. The change of CgB distribution seems to be 
specific because it was not accompanied by a redistribution of Ins, which remained 
confined to the core of SGs. Different results were obtained from the analysis of Ins, 
CgB and CgA intra-granular distribution in p cells by 359. CgB was reported to be 
confined to the granule core in mature p cells, whereas it was observed throughout the 
granule matrix (halo+core) during ontogeny. Our data, in apparent contradiction to the 
latter findings, have been however obtained under completely different conditions, i.e. 
rat cell culture instead of pig pancreatic tissue sections. In addition, the different 
techniques used for the ultrastructural immunocytochemistry might also account for 
some discrepancy.
It was previously proposed that granins bind to granule membrane at low pH and high 
Ca2+ 89, 360. Our findings of a peripheral redistribution of CgB within SGs upon Ca2+ 
mobilisation with iono and elevated extracellular glucose appear to be more in
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agreement with a possible binding of CgB to the granule membrane upon Ca 
elevation.
The dynamic redistribution of a secretory protein in the SG lumen upon stimulatory 
conditions had never been reported so far. Other organelles, such as ER, mitochondria 
and GC, can modify their internal environment in response to changes of the cytosolic 
milieu 361. Some changes, for example accumulation and release of Ca2+, have been 
reported to occurr in (3 cell SGs ’ , but the experimental evidence and the
physiological importance of those findings are still debated. Our results suggest that the 
iono-induced changes of the cytosolic Ca2+ concentration may trigger a partial re­
organisation of the granule core determining a prevalent distribution of CgB to the core 
periphery and halo. The functional significance of this redistribution is not clear, 
however there might be a correlation between the distribution and the release of 
secretory proteins. In fact, in SGs of PC 12 cells the catecholamines localised 
preferentially in the halo have been proposed to be ready releasable through the fusion 
pore 75, 364. Similar hypotheses have been proposed for the release of C-peptide from 
Ins-containing SGs 73.
When INSl-E cells were strongly stimulated by SM, we observed a parallel Ins and 
CgB release, suggesting a concomitant discharge of all SGs. However, with 
concentrations of iono <1 pM only CgB was released, while with larger iono 
concentrations, and also with PMA, the percentage contribution of CgB exceeded that 
of Ins. These results strongly suggest that the various SGs are not equally sensitive to
the second messengers and signals. In particular, the CgB-rich SGs appear much more
^ |
sensitive to Ca than the Ins-containing granules. A mediator of such differential 
sensitivity might be PKC, a well known target of PMA which can be also activated by 
ionomycin-induced Ca2+ influx across the plasma membrane 400. According to this
possibility, CgB might be preferentially released by PKC. Furthermore, PMA mobilises 
Ca2+ along the PLC pathway. An alternative possibility would be that PMA induces in 
our experimental model a Ca -dependent exocytosis of CgB. It was indeed suggested 
that Ca2+ is released locally by PMA stimulation, as well as by ionomycin 399. Whatever 
the mechanism, Ca appears to be a critical player in the prefential release of CgB 
induced by ionomycin and PMA.
A differential secretion of CgB raises the question whether CgB is release from a CgB- 
enriched granule pool or from Ins- and CgB-containing granules. In this framework, an 
additional process that might contribute to the differential release of Ins and CgB is the 
redistribution of the latter within SGs occurring upon cell stimulation, however at the 
moment the role of this process was not precisely evaluated.
2. Lessons from Rin-5AH cells heterogeneity
2.1. Dissociation in the expression and secretion o f Ins and CgB 
While studying the dissociation in the intracellular distribution and secretory behaviour 
of Ins and CgB in various p-cell models, we observed that Rin-5AH cells appeared 
heterogeneous with regard to the expression of both proteins. Rin-5AH cells are a clone 
derived from the radiation-induced rat insulinoma Rin, which is composed of Ins-, 
glucagon- and somatostatin-secreting cells 365. Rin-5AH clone has been characterised as 
a bona fide (3 cell line because it expresses only Ins 342, 366’ 367, and we could also 
confirm the lack of glucagon expression at both the mRNA and protein level (not 
shown). Therefore, the heterogeneity of Ins and CgB expression is not due to the 
presence of cells with different hormonal specificities but rather to a differential
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expression of the two proteins. Rin-5AH cells have been traditionally considered to 
display traits of immature p cells j66, mostly because of their low Ins content as 
compared to other insulinomas and to primary (3 cells. We disagree with this 
interpretation mainly because, when a battery of transcription factors was investigated 
in Rin-5AH as compared to INS1-E cells, we found no difference in the pattern of 
expression of these factors implicated in the terminally differentiated p cell phenotype 
(Table 1 and Fig. 1). We rather hypothesise that the low Ins content and the poor 
secretory performance of Rin-5AH cells is due to a perturbed secretory function.
Isll PdXl NeuroD/B2 Nkx2.2 Nkx6.1 Pax6
INSl-E + + + + ■f +
Rin-5AH + + + + + +
Dl + + + + + +
D2 + +- 4- + + +
Q2 + ■f + + + +
Q6 + + + + + +
Table 1 -  Expression analysis of transcription factors involved in the terminal 
development of p cell phenotype. The expression of the transcription factors reported 
in the table was analysed in Rin-5AH cells. + indicates presence.
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Fig. 1 -  A model of the hierarchy of transcription factors involved in pancreas 
development 368. PdX-1 marks the territory of the future pancreas. Later it becomes 
restricted to (3 and delta cells. Ngn3 expression starts at early stages, increases to a peak 
and decreases thereafter. It is turned off prior to final differentiation. The expression of 
NeuroDl, also called B2, can be induced by ngn3. Pax4 is not necessary for the 
development of early Ins-expressing cells, but is required for their maturation and 
maintenance. Nkx2.2 protein expression becomes progressively restricted to the alpha, p 
and PP cells of the mature islet. Nkx2.2 is required for terminal differentiation of P cells 
and maintenance of Nkx6.1 expression. Nkx6.1 protein is initially broadly expressed and 
becomes progressively restricted; in the adult pancreas Nkx6.1 is only present in p cells. 
In newborn mice, Pax6 is expressed in mature alpha, p, delta and PP cells. Isll is 
involved in the early formation of the pancreas. At early stages all the glucagon positive 
cells express Isll. Later, Isll is detectable in all the islet cells.
2.2 Rin-5AH sub-clones
In an attempt to understand more in depth the phenotype of the four different 
subpopulations composing Rin-5AH cells we tried to isolate them on the basis of their 
positivity or negativity for Ins and CgB (Ins+/CgB+; Ins+/CgB'; Ins'/CgB+; Ins'/CgB'). 
Despite the observation of cells devoid of any Ins and CgB signal in the Rin-5AH 
population it was not possible to isolate such a sub-clone, possibly because the Ins' 
/CgB' cells reflect a transient functional state of some cells.
The investigation of the secretory behaviour of Rin-5 AH parental cells and the four sub­
clones selected gave us some insights into the possible molecular defects underlying the 
poor secretory behaviour of this cell model.
Responsiveness to the stimulatory treatments varied among the sub-clones, suggesting 
that they could be useful tools to investigate differences in trans-membrane signalling 
and/or the processes regulating SG exocytosis. While no significant differences were 
observed when stimulating cells with KCl/glucose, except for D1 sub-clone, application 
of the SM yielded variable release not only of Ins, but also of CgB. Two sub-clones 
appeared particularly interesting, namely D2 and Q2. D2 sub-clone showed normal Ins
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content and basal release, however Ins stimulated secretion was lower as compared to 
parental cells. In addition, this sub-clone displayed very low CgB levels. Indeed, the % 
CgB release, apparently comparable to parental cells and other sub-clones, was 
sustained by a low amount of the protein. In fact protein release is measured as the % of 
the total content of the secreted protein. Intriguingly, D2 cells also displayed a very low 
VAMP2 and SYP levels. This might reflect either a low granule content, or a defective 
equipment of the cells in terms of the molecular machinery implicated in regulated 
exocytosis. In line with this observation is the fact that Ins secretion from D2 cells is 
lower than that in Rin-5 AH parental cells. Taking in account that in other cellular 
systems the granins, and in particular CgA, have been proposed to play a structural or a
TO O/TQ
sorting role during granule generation ’ ’ , it may be interesting to study whether
CgB has any role in Ins granules biogenesis and secretion.
Q2 sub-clone attracted our attention because it showed a lower Ins release compared to 
parental cells, despite a similar content, and a higher CgB content which was not 
accompanied by a similarly high release. Together with the strong accumulation of both 
Ins and CgB at the GC/TGN level, these results led us to hypothesise a condition of 
cellular stress, which induces a functional impairment.
2.2.1 Constitutive secretion o f Ins in Rin-5 AH cells and sub-clones 
Interesting results came from the analysis of constitutive secretion of Ins in Rin-5 AH 
cells and sub-clones. Pre-treatment of the cells for few hours with the inhibitor of 
protein synthesis CHX in the absence of secretagogues causes, along with block of de 
novo protein synthesis, the release of proteins stored within constitutively released 
vesicles, while retaining those stored within SGs 370. When applied to Rin-5AH cells 
and the four clones derived therefrom, this procedure revealed a considerable decrease
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in basal Ins release only in Q2 cells, however with no effect on stimulated one. This 
result suggests the existence in this sub-clone of a diversion of a fraction of the hormone 
to a constitutive (or constitutive-like 44) pathway, which sustains its continuous release 
independently from stimulation. By contrast, the high basal Ins release of Q6 sub-clone 
was not modified by cell pre-incubation with CHX, thus excluding in this clone a high 
constitutive secretion. A possible explanation of our results is the spontaneous 
exocytosis of SGs occurring at high rate in resting conditions.
A feature of Rin-5 AH cells that was noticed in the context of the present study, as 
compared to other (3 cell models, is the predominant accumulation of Ins 
immunoreactivity in the GC/TGN area. One explanation for this may be a slower 
conversion ability of pro-ins into Ins, which occurs during granule maturation 39, 371, 
despite the expression of the responsible enzymes, PC 1/3 and PC2 expression (not 
shown). We could not investigate the relative proportions and distribution of the 
hormone and its precursor, since the different antibodies available for this analysis 
recognise both forms. In addition, a clear GC/TGN accumulation was seen, especially in 
Q2 and Q6 sub-clones, also for CgB, a granule protein that does not undergo processing 
in p cells. Thus, the low efficiency of organelle transport along the GC-granule pathway 
appears to be a general property of Rin-5AH cells, possibly valid also for the other 
secretory proteins expressed by this line.
2.3 SNAREs machinery
An initial attempt to assess whether the differential expression of proteins involved in 
the secretory machinery could explain the secretory features of Rin-5 AH cells and the 
sub-clones derived therefrom was performed by the analysis at the protein level of the 
SNAREs Stxl, VAMP2 and SNAP-25, as well as of the Stx-controlling protein
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9-1-Muncl8-1 and the Ca sensor synaptotagmin I. We did not observe any difference in 
the expression of the aforementioned markers among the cells of the parental line and 
the sub-clones, except for VAMP2, which appeared significantly less expressed in D2 
cells. In the future expression by transfection of VAMP2 in the D2 sub-clone could be 
useful to investigate the role of this protein in Ins secretion.
Concerning the other neurosecretory markers, they undergo post-translational
1 9  C 9*79modifications ’ , therefore their expression does not rule out the possibility of a
different functional state in the subclones.
Beside dense core secretory granules (DCSGs), pancreatic p cells also contain synaptic- 
like microvesicles (SLMVs), which cycle between the plasma membrane and the early 
endosome compartment. SLMVs store 373 and release 374 by regulated exocytosis the 
neurotransmitter y-aminobutyric acid (GABA), which has been proposed to play a 
paracrine and/or an autocrine role in islets physiology. Some characteristics of p 
cell SLMVs resemble those of the acetylcholine-containing small synaptic vesicles 
(SSVs) of neuroendocrine cells such as PC12 62’377; for instance, they show much faster 
kinetics than DCSGs and are released at lower Ca2+ concentrations. In pancreatic p cells 
some proteins involved in the regulated exocytosis, such as VAMP2, are shared by
o
DCSGs and SLMVs , whereas others are present on either vesicle type. This is the 
case for synaptotagmin III, that is only present on SGs 379, and SYP, which is restricted 
to SLMVs 373,378, 379. Taking this in account, we hypothesised that the low content of 
SYP and VAMP2 in the D2 sub-clone could reflect a reduced number o f SLMVs. If  this 
was true, this sub-clone could be an interesting also for investigating the effect of a 
reduced GABA release on Ins secretion.
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3. Revisiting RIN-5AH cells: a cell model of oxidative stress
In the effort to identify the possible cause of the secretory behaviour of Rin-5 AH cells 
and sub-clones we found that the latter are unable to synthesise ATP upon stimulation 
of Ins secretion. Furthermore, the lack of ATP production was accompanied by an 
increase in ADP levels suggesting also the existence of ATP consuming activities in 
these cells. This led us to suspect that Rin-5AH cells have a metabolic impairment 
leading to cellular stress. In order to investigate this issue we focused on the Q2 sub­
clone, that displayed a strong accumulation of Ins and CgB in the GC/TGN and a poor 
secretory behaviour.
3.1 Mitochondrial function
In Q2 cells mitochondria appeared swollen and fragmented, the A\jfm was lower as 
compared to INS1-E cells, and its increase upon stimulation of Ins secretion showed a 
kinetics different from that observed in the latter cells. Low A\|/m levels can be due to a 
loss of A'Pm, caused by a perturbation of the ETC. This affects ATP production, 
mitochondrial Ca2+ influx 230 and the ability of mitochondria to undergo 
hyperpolarisation upon stimulation of Ins secretion. Ca2+ homeostasis is crucial for a 
correct cell functionality: an impairment of Ca2+ handling may affect protein folding in 
the ER 285, Ca2+ cross-talk between ER and mitochondria 230, 231, leading to impaired 
ATP production 185, and malfunctioning of many intracellular signalling pathways. In 
the attempt to investigate whether a low mitochondrial [Ca2+] could underlie the 
defective secretory behaviour of Q2 cells, the latter were treated with CGP-37157, a 
benzothiazepine inhibitor of the mitochondrial Na+-Ca2+ exchanger, leading to an 
increased intramitochondrial Ca2+ level 232. The improvement of Ins secretion, albeit
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slight, observed in CGP-37157-treated cells suggests that the perturbed Ca2+ 
mobilisation does indeed play a role in the secretory behaviour of Q2. This might reflect 
an impaired mitochondrial Ca2+ influx, due to, or causing, the observed low A\|/m. A 
more in depth investigation of the mitochondria of Q2 cells will help further elucidate 
the mechanisms responsible for these defects.
In the framework of a loss of A'Pm, which affects on one hand mitochondrial ATP 
production and on the other hand mitochondrial Ca2+ influx, we interpreted our finding 
regarding UCP2 protein levels as a possible link between the two events. UCP2 plays a 
clear role in decreasing the A'Pm, by inducing a proton leak from the ETC and 
subsequently dissipating the electrochemical gradient as heat. The energy stored in the 
electrochemical gradient is therefore uncoupled from ATP synthesis. As discussed in 
Sections 2.2 and 2.4 of Introduction, UCP2 over-expression can be regarded as a 
defensive mechanisms upon oxidative stress, because it can lower A\}/m by causing a 
faster electron flow, which would decrease ROS formation 218. UCP2 was indeed shown
0 0 1  O 1 0to be activated by O2’ , and proposed to act also as anion carrier , thus transporting
O2' out of mitochondria and therefore protecting them from ROS. In the case o f Q2 
cells, a perturbed mitochondrial function, accompanied by higher UCP2 levels as 
compared to INS IE cells, might underlie a state of oxidative stress. The side effect of 
such a defensive mechanisms would be inevitably an impairment of Ca2+ influx, due to 
perturbed ATP production. In fact, the A\|/m is the driving force for mitochondrial Ca2+
0 4 - A A A ________________ _
influx . Upon Ca uptake, A\|/m is depolarised and ATP production is thought to 
restore it. If UCP2 lowers A'Pm and impaires ATP production, mitochondria can not 
drive any longer Ca2+ uptake. This hypothesis would be supported by the effect of CGP- 
37157 on restoration of A\|/m and Ins secretion.
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Taken together, our findings of mitochondrial morphological and functional alterations 
led us to hypothesise that Q2 cells undergo oxidative stress causing impaired Ins 
secretion, accompanied by elevated ROS production 191, as observed in both type 1 247, 
248 and type 2 diabetes 249-25ROS are generated by several intracellular sources, among 
which are mitochondria. Here ROS production occurs during respiration by an electron 
leakage from the ETC 185’186’188. Mitochondria are also important intracellular targets of 
ROS. Thus uncontrolled accumulation of ROS can cause perturbation of mitochondrial 
function by means of alterations in mtDNA, mitochondrial proteins or lipids. Finally, 
mitochondrial mutations can cause increased production of ROS, which in turn worsen
i o /r
the situation . It will be of great interest to measure ROS levels in Q2 cells, as 
compared to INS1-E. We predict that ROS levels in Q2 cells are higher. Incubation 
with ascorbic acid, a mild ROS scavenger, did not yield any improvement of Ins 
secretion, however we observed a redistribution of the cell population to higher A\|/m, 
suggesting that a stronger or more targeted antioxidant treatment might be able to 
significantly improve Ins secretion in Q2 cells 38°.
Finally, under chronic oxidative conditions, the A\|/m is lowered, intracellular ATP is 
decreased and several pro-apoptotic proteins, among which the cyt c, are released from 
mitochondria because of the membrane permeability increase, leading to activation of 
caspases and apoptosis 5 . These aspects are all currently investigated in the Q2 cell
model. The cell viability was comparable to that o f INS1-E cells, however we cannot 
rule out the possibility that in Q2 cells early apoptotic pathways are induced, because 
we have not measured the activation of caspases.
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3.2 Mitochondrial morphology
Upon glucose up-take and metabolism, liver cells mitochondria undergo morphological 
changes, such as fragmentation. These changes seem to be required for glucose 
metabolism and ROS over-production 381. Round-shaped mitochondria are considered 
to be more active because of the increased surface area; therefore, when ATP is 
required, mitochondria are converted from a filamentous meshwork to round-shaped, 
separate structures 224. The need of ATP in Q2 cells, which are unable to produce it 
upon stimulation of Ins secretion, could account for the presence of round-shaped 
mitochondria. Our findings may be interpreted as a perturbation of a physiological 
phenomenon. In fact, we found fragmented and swollen mitochondria not only in 
culture conditions (11 mM glucose: stimulatory), but also at resting conditions (2.8 mM 
glucose). This might reflect an over-activation of mitochondria, possibly necessary to 
overcome the low overall mitochondrial functionality. If  this were the case, the over­
activation of mitochondria should be reflected by high basal ATP levels and oxygen 
consumption. Indeed we have observed higher basal ATP levels in Q2 cells with respect 
to Rin-5AH. However this observation is still preliminary and needs further 
confirmation.
3.3 Q2 cells as a type 2 diabetes cell model
The morphological and functional alterations of mitochondria in Q2 cells were similar 
to those described in p cells of type 2 diabetes patients 228,229. This led us to formulate 
the intriguing hypothesis that the Q2 sub-clone might be a cell model o f oxidative 
stress. The relevance of this possibility is intuitive, since the study of oxidative stress in 
diabetes is currently being carried out on p cell models by application of agents, such as 
H2 O2 , which lead to cell death. A cell line, characterised by a chronic oxidative stress,
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may mimic the patho-physiological state of p cells in type 2 diabetes patients and could 
thus be useful for validating therapeutic strategies based on counteracting oxidative 
stress.
The low Ins content and the impaired Ins release of Rin-5 AH and Q2 cells, as compared 
to a good p cell model such as INS1-E cells, may be regarded as effects of oxidative 
stress. In particular, a very intriguing parallelism can be observed between the secretory 
behaviour of Rin-5 AH and Q2 cells and the effects of FA-induced oxidative stress. The 
latter causes an increased basal Ins secretion and a decrease of stimulated release. 
Nevertheless, cells can still respond to secretagogues, acting directly on K a t p  channels, 
thus by-passing regulation by the ATP source, the mitochondria. In addition, upon FA- 
induced oxidative stress, ATP levels and A\|/m are lowered, whereas the expression of 
UCP-2 is increased 280. One interesting aspect of further investigation in Q2 cells will be 
the fatty acids metabolism, which could lead to their accumulation in mitochondria, 
rather than to their oxidation and elimination. This would cause a chronic oxidative 
stress and could explain well-known features of Rin-5 AH cells and Q2 cells, such as the 
impaired Ins secretion and Ins gene expression ’ . The same features have been
described in p cells undergoing oxidative stress obtained by elevated levels of both 
glucose257 258’259.
4. ER stress in fi cell models
Pancreatic p cells are highly engaged in Ins synthesis, processing and regulated 
secretion. They have a very developed ER, whose folding capacity must counterbalance 
the protein overload determined by an increase of Ins demand, thus adapting to
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physiological stress. Several patho-physiological conditions, such as hypoxia, 
hyperglycemia, mutations which impair protein folding, can lead to ER stress . In the 
case of pancreatic p cells, mutations of the Ins2 gene 335 or of proteins implicated in the 
UPR 337 lead to ER stress and diabetes (see Section 3.2 of Introduction).
Since ER and oxidative stress are both proposed to be induced under patho­
physiological conditions 2 8 282, we asked whether a cell model bearing oxidative stress 
is more susceptible to ER stress induction. In this context our finding that INS1-E cells 
show higher levels of BIP mRNA as compared to the Q2 sub-clone might indicate that 
INS1-E, while releasing actively Ins, undergo physiological stress and trigger a 
protective response, whereas this response in Q2 cells is less effective. Moreover, the 
higher levels of the XBP-1 spliced form in the latter cell model might reflect a higher 
need for chaperones.
We tested our hypotheses by inducing a sub-lethal ER stress to mimic a chronic ER 
stress. Under the experimental conditions chosen, i.e. incubation for 6 hours in the 
presence of 3 pM Tg, our reference cell model (INS1-E) showed no significant increase 
of apoptosis. By converse, Q2 cells appeared more sensitive to Tg treatment, suggesting 
that they may be more susceptible to ER stress induction.
An important observation concerns the induction of some stress markers in Q2 cells 
upon Tg treatment: the expression of ATF4 and, more markedly, of CHOP, was higher 
in Q2 cells than in INS1-E. By contrast, in INS1-E the treatment induced a higher 
expression of BIP and of the spliced form of XBP-1. These results could therefore 
suggest a higher sensitivity of Q2 to ER stress and a faster induction of apoptosis as 
compared to INS1-E, which appear actively engaged in the UPR. In the future it will be 
interesting to test this hypothesis by measuring the apoptosis at earlier stages of ER 
stress (<6 hours Tg treatment) and by assessing the activation of signalling pathways
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implicated in apoptosis induction, e.g. those of caspases.
4.1 Effects o f ER stress on regulated secretion
ER stress is associated to impaired glucose-induced Ins secretion. It has been proposed 
that a physiological UPR induction regulates the glucose-depending Ins synthesis, thus 
coupling supply and demand and preserving ER function 292. According to this model, 
at resting glucose concentrations pro-ins translation is attenuated by the PERK pathway, 
whereas it is induced at stimulatory glucose levels. Under patho-physiological 
conditions, such as Ins resistance, the Ins demand increases and the high rate of pro-ins 
translation exceeds the folding capacity of the ER. This leads to accumulation of pro- 
Ins, reduced granule biogenesis and Ins secretion dysfunction 338. In this context it is 
intriguing that Q2 cells show features, such as the accumulation of Ins at the level of the 
GC (suggestive of a defect in protein maturation), a smaller number of granules as 
compared to INS1-E and a poorly efficient Ins release. Taken together with the apparent 
lower capacity to overcome ER stress, these results suggest that Q2 cells are more prone 
to the establishment of ER stress conditions.
Little is known about the effects of ER stress on other components of SGs and of the 
secretory machinery. It has been shown that upon 24 hours exposure of rat primary p 
cells to the cytokine ILlp (interleukin 1), SNAP25 and VAMP2 are down-regulated, 
decreasing the granule docking and exocytosis of the cells 383. Cytokines cause ER 
stress , therefore the decreased Ins secretion occurring upon ER stress may be due to 
a lower exocytotic rate.
We investigated the effects of a sub-lethal ER stress on the expression of some proteins 
of the secretory machinery and on Ins and CgB secretion in INS1-E and Q2 cells. Our 
analysis showed that in INS1-E cells, while Ins mRNA levels decrease upon stress
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induction more markedly than in Q2 cells, the expression levels of CgA, CgB, 
ICA512/IA-2 and SNAP25 remain unchanged, whereas they slightly increase in Q2 
cells. These results might suggest a differential regulation of the mRNA of Ins and some 
granule proteins, such as CgA, CgB and ICA512. Furthermore, the mRNA levels of 
SYP remain unchanged upon stress induction in both INS1-E and Q2 cells. This 
suggests that ER stress affects p cell SGs, but not SLMVs.
We therefore investigated the effect of ER stress on protein secretion with regard to Ins 
and CgB release. In INS1-E cells the % Ins release upon Tg treatment was similar to 
that of control cells, despite the decrease of both Ins mRNA and protein. In Q2 cells, 
where the reduction of Ins mRNA upon stress induction was smaller, we observed an 
increase of basal Ins release together with a decrease of its stimulated secretion. This 
suggests that in these cells more Ins is released by constitutive secretion upon stress 
induction. It would be interesting to evaluate the proportion of Ins constitutively 
released by pre-incubation with CHX.
In order to evaluate also the CgB release in our cell models following Tg treatment we 
performed a preliminary experiment. The results showed that CgB secretion was not 
affected by stress induction, suggesting that the two granule proteins are differently 
sensitive to ER stress.
The effect of ER stress on Ins and other granule proteins might be due to a different 
regulation of their transcription or, alternatively, to a different stability of their mRNA. 
The latter hypothesis would be of great interest, because so far only a mechanism of 
mRNA stabilisation has been described, which is common to Ins, CgA and CgB 385.
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5. Conclusions
In the present work we have gained insights into the molecular mechanisms underlying 
Ins and CgB secretion in pancreatic p cells. Despite their different embryonic origin, p 
cells share with neurons and other endocrine cells a number of properties and molecular 
mechanisms, collectively known as neurosecretion competence. Moving from other 
neuroendocrine systems, where granins such as CgB are often expressed and thought to 
play a role in secretory granule biogenesis, we investigated the relative distribution of 
CgB in p cells, demonstrating for the first time a partial dissociation between this 
protein and Ins at the level of SGs. Our findings of a dynamic intra-granular 
redistribution of CgB under stimulatory conditions and of a functional dissociation of 
their regulated release upon Ca2+ influx, clearly suggest the possibility that in p cells 
secretory proteins are differently regulated. The highly heterogeneity of one of our cell 
models (the Rin-5AH cell line) with regard to Ins and CgB expression further confirmed 
our hypothesis of a differential regulation of the two proteins and raised questions about 
the interrelation of either protein with respect to the regulated secretion of the other. In 
particular, we could isolate a sub-clone, the D2, expressing very low levels of CgB and 
displaying a poor efficiency of Ins secretion, which represents a useful tool to further 
investigate the possible role of CgB in Ins release.
After a preliminary characterisation of Rin-5 AH cells we concluded that this insulinoma 
does not display immature traits, as previously proposed, and rather regarded its poor 
Ins content and secretion as a possible effect of a perturbed secretory function. The Rin- 
5AH cell line may thus represent a cell model of endogenous stress, rather than of p cell 
function. The functional alterations observed in the Q2 sub-clone, in particular at the 
level of mitochondria, led us to hypothesise that Rin-5 AH cells bear oxidative stress. It
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will be very interesting to characterise the levels of ROS and other markers of oxidative 
stress in Q2 cells. The intriguing parallelism between our cell model and some features 
observed in type 2 diabetes patients suggests that Q2 cells might be a useful tool to gain 
further insights into the correlation between oxidative stress and Ins secretion 
dysfunction under chronic stress conditions. So far these studies are most often carried 
on (3 cell models by induction of oxidative stress, which leads to cell death.
Finally, our observation that a cell model possibly carrying oxidative stress is more 
susceptible to ER stress induction, as compared to a good p cell model (INS1-E cells), 
may shed a light on the correlations between oxidative stress, ER stress and Ins 
secretion dysfunctions. Under diabetic and other patho-physiological conditions both 
stress may be observed, however very little is known about the causative mechanisms 
and there is no knowledge about the effects of ER stress on the secretory machinery. We 
plan to investigate in more detail the regulation of proteins implicated in exocytosis 
under ER stress, which appears to be independent from that of Ins, as suggested by our 
preliminary results about mRNA expression and protein secretion.
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C hapter 4
M ATERIALS A N D  M ETH O D S
Cell cultures
Cells and growth media
The cell lines used in the present work are: INS1-E 386, kind gift of M. Solimena 
(University of Technology, Dresden, Germany); RIN-5 AH 387; P-TC3 388. Human islets 
were obtained from post-mortem donors and kindly provided by F. Bertuzzi (San 
Raffaele Hospital, Milan, Italy).
Cells were grown at 37°C, under a 5% C02 humidified atmosphere, in RPMI1640 or 
DMEM (11 mM glucose) media supplemented with 10% fetal clone serum III 
(Hyclone, Utah, USA), 100 U/ml penicillin/streptomycin and 2 mM ultra-glutamine 
(Cambrex Bio Science, Italy). The medium for INS1-E cells was supplemented also 
with 1 mM pyruvate (Cambrex Bio Science, Italy), 10 mM Hepes pH 7.4 and 50 pM p- 
mercaptoethanol; that for RIN-5AH cells with 1 mM pyruvate. Human islets were 
grown for 2 days after isolation in RPMI 1640 containing 10% serum.
105
For all the analyses only early to medium (12-25) passages were used, being RIN-5 AH 
cells little characterised for stability. The same standard was also adopted for INS IE 
cells, although their stability in long term culture has been well characterised34!.
Subcloning
A subcloning by limited dilution was performed on Rin-5AH cells, plating 0.5 
cells/well in a 96 well plate. When the clonal subpopulations were visible at the 
microscope, they were picked up and transferred to a 6 well plate, then the subclones 
were expanded for the morphological analysis. All the subclones derived showed a 
similar grow rate and they were cultivated in the same growth medium.
Subcellular and ultrastructural analysis
Antibodies
The antibodies used for immunofluorescence, Western blotting and immunoelectron 
microscopy are listed below. The polyclonal antibodies were: a guinea pig polyclonal 
anti-ins (DAKO, Italy); two rabbit polyclonal anti-CgB: PE-11 389 and an antibody 
generated by 390 (generously provided by P. Rosa, CNR Institute of Neurosciences, 
Milan, Italy); rabbit polyclonal anti-synaptotagmin I (Synaptic Systems, Goettingen, 
Germany); goat polyclonal anti-dopamine-P-hydroxylase (Santa Cruz, CA, USA); anti- 
CgA GE-19 (kind gift of Dr. Andrea Laslop, Innsbruck, Austria); anti-Munc-18 
(Synaptic Systems, Goettingen, Germany); anti-UCP2 (Santa Cruz, CA, USA). The 
mouse monoclonals were: IgG2a anti-CgB, CIRO 391, available in our laboratory; anti- 
ins (SIGMA-Aldrich, Italy); anti-TGN38 and anti-GM130 (Transduction Laboratories,
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BD Biosciences, San Jose, CA USA); two anti-IA2: mICA512cyto 392 (kindly provided 
by M. Solimena, University of Technology, Dresden, Germany) and 76F 393, available 
in our laboratory; anti-CgA LK2H10; monoclonal anti-synaptophysin I (mAb38; 
Boehringer, Mannheim, Germany); monoclonal anti-syntaxin I (SIGMA-Aldrich, Italy); 
anti-VAMP-2/synaptobrevin-2 (Synaptic Systems, Goettingen, Germany); anti-tubulin 
(SIGMA-Aldrich, Italy). Anti-SNAP23 and anti-SNAP25 were kindly provided by M. 
Matteoli.
The secondary antibodies fluorescein (FITC)- and indodicarbocyanine (CY5)- 
conjugated goat anti-mouse and goat anti-rabbit, and the rhodamine (TRITC)- 
conjugated donkey anti-guinea pig were purchased from Jackson ImmunoResearch 
Europe Ltd. (Soham, UK). The horse-radish peroxidase (HRP)-conjugated anti-rabbit 
and anti-mouse secondary antibodies were from Biorad (Biorad laboratories, Italy).
Immunofluorescence analysis
The cells were plated at low density on 100 pg/ml poly-L-lysine (SIGMA-Aldrich, 
Italy)-coated 24 mm coverslips two days before the analysis. The cell monolayers were 
fixed for 20 min at room temperature (RT) with 3% paraformaldehyde dissolved in PBS 
pH 7.4, quenched with 15 mM glycine in PBS for 5 min, and washed with PBS. The 
cells were then permeabilised for 4 min with 0.2% (weight/volume, W/V) Triton X-100 
in PBS, washed and the unspecific antibody binding was blocked by incubating with 
0.2% (W/V) gelatine in PBS for 10 min. The cells were incubated at RT for 1 hour with 
the primary antibodies diluted in the following goat serum dilution buffer (GSDB): 
0.2% (W/V) gelatine, 16,5% (W/V) Normal Goat Serum (Sigma-Aldrich), 0.3% (W/V) 
Triton X-100, 20 mM phosphate buffer pH 7.2, 0.45 M NaCl, PBS). The coverslips
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were then washed with 0.2% (W/V) gelatine in PBS and incubated at RT for 45 min 
with the fluorescent conjugated secondary antibodies diluted in GSBD. After extensive 
wash with 0.2% (W/V) gelatine in PBS and PBS the coverslips were finally mounted in 
gelvatol and let dry at RT overnight. In the immunofluorescence with human islets, 
before mounting with gelvatol the coverslips were incubated for 5 min with 1 pg/ml 
DAPI (2-(4-Amidinophenyl)-6-indolecarbamidine dihydrochloride; SIGMA-Aldrich) to 
label the nuclei.
Cell were observed under either a confocal microscope (Leica TCS SP2) or a 
fluorescence microscope (DeltavisionTM, Applied Precision, Issaquah, WA, USA), 
with a 60x objective at a resolution of 1024x1024. Image deconvolutions and 
tridimentional cell reconstructions were performed by the DeltavisionTM wide-field 
microscopy system by z-stack 150 nm optical sections acquisition and processing by the 
softWoRx® software (Applied Precision, Issaquah, WA, USA). Exported tiff files were 
assembled into figures with Adobe Photoshop CS v.8 for MacOS X, according to the 
code of image-manipulation ethics 394.
Electron microscopy
Conventional electron microscopy (EM) was performed in Epon-embedded ultrathin 
sections of cells fixed with (W/V) glutaraldehyde (2%) and Os04 (2%), as described in 
395. For immunoelectron microscopy, INS1-E cell pellets were fixed at room 
temperature in a mixture (W/V) of 4% formaldehyde and 0.2% glutaraldehyde, washed 
in 100 mM phosphate buffer pH 7.4, dehydrated in ethanol and infiltrated in LR white 
resin (Polyscience Europe GmBH, Eppelheim, Germany) which was polymerised for 24 
hours at 50°C. Embedded samples were cut on an Ultracut microtome (Leica
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Microsystems, Wetzlar, Germany), incubated with monoclonal anti-ins (1:100) and 
polyclonal anti-CgB (1:100) diluted in phosphate buffer, then washed and reacted with 
goat anti-mouse and goat anti-rabbit Ig-coated colloidal gold particles (6 and 12 nm, 
respectively). After extensive washes, the grids were exposed to uranyl acetate and lead 
citrate and finally examined in a LEO 912AB electron microscope.
Quantification of labelled SGs was performed on printed micrographs (at least 20 for 
each condition). Labelled granules were counted manually by point counting. Results 
were expressed as percentages of total granules counted in the different experimental 
cell groups, both as a whole and depending on their gold particle localization in the two 
subcompartments, the core and the core periphery/halo.
Protein expression analysis
SDS-PAGE and Western Blotting
The cells monolayers were solubilised on ice in lysis buffer (50 mM Hepes pH 7.5, 150 
mM NaCl, 15 mM MgCl2, 1 mM EGTA, 10% glycerol, 1% Triton X-100) 
supplemented with a proteases inhibitor cocktail (0.5 mM PMSF and CLAPA: 8.25 mM 
chymostatin, 10.5 mM leupeptin, 8.25 mM antipain, 7.5 mM pepstatin A, 0.75 mM 
aprotinin; all were purchased from SIGMA-Aldrich, Italy), then kept on ice for at least 
30 min and finally centrifuged at 13,000 rpm for 15 min. The supernatants containing 
the soluble proteins was stored at -80°C. The total protein content was measured by 
BCA assay (Pierce), then 25 pg of each sample were diluted in a loading buffer (0,125 
M Tris-HCl pH 6.8, 5% SDS, 20% glycerol, 2% Bromophenol Blue in ethanol, 5% P-
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mercaptoethanol), denatured and separated by SDS-PAGE on acrylamide gels prepared 
at the suitable percentage. The proteins were then transferred on 0.22 pm nitrocellulose 
membranes (Schleicher&Schuell Italy) in a Western blot apparatus (Biorad laboratories, 
Italy) overnight.
Development o f nitrocellulose membranes
The nitrocellulose membranes from both Western blotting and dot blots were blocked 
for 1 hour with a blocking solution (5% non-fat milk in PBS-0.1% tween-20), incubated 
for 1 hour with the primary antibody diluted in PBS-2% BSA, thoroughly washed with 
PBS-0.1% tween-20 (T-PBS) and incubated for 1 hour with the appropriate HRP- 
conjugated secondary antibody (Biorad laboratories, Italy) diluted in the blocking 
buffer. After extensive wash with blocking buffer and with T-PBS, the membrane was 
finally developed by ECL system (Amersham, Life Sciences, Italy).
Secretion assays
Pharmacological treatments
Cycloheximide — All the incubations in low glucose KRH (see below) with or without 
stimuli were performed in the presence of 20 pg/ml cycloheximide (CHX; SIGMA- 
Aldrich, Italy), in order to inhibit protein synthesis.
CGP-37157 - Upon incubation for 1 hour in low glucose KRH, the cells were pre­
treated with 20 pM CGP-37157 (7-Chloro-5-(2-chlorophenyl)-l,5-dihydro-4,l- 
benzothiazepin-2(3H)-one; Calbiochem, Merck Biosciences, Germany); a specific
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inhibitor of the mitochondrial Na+ -Ca2+ exchanger) for 4 min at 37°C. The cells were 
then stimulated or not for 20 min with SM in the precence of CGP-37157.
Ascorbic acid - The cells were treated for 20 hours with 250 pM ascorbic acid (SIGMA- 
Aldrich, Italy) freshly solved in water. The day after a new solution of ascorbic acid was 
prepared and added during the incubation with low glucose KRH (see below) for 1 hour 
and the following 20 min of stimulation with SM or resting conditions.
Thapsigargin -  The SERCA2b inhibitor thapsigargin (Tg; SIGMA-Aldrich, Italy), 
dissolved in DMSO, was added at the final concentration of 3 pM to the culture media. 
Control and treated cells were respectively incubated with DMSO alone or Tg for 6 or 
24 hours.
Secretion assays
Each experiment was performed in triplicate and repeated at least three times. Cells, 
plated three days before the experiment and used at sub-confluence, were incubated at 
37°C for 1 hour in modified, low (2.8 mM) glucose Krebs-Ringer bicarbonate buffer 
(KRH: 4.8 mM KC1, 1.2 mM M gS04, 10 mM Hepes pH 7.4, 2 mM KH2P 0 4, 8.3 mM 
NaHCOs, 134 mM NaCl, 2 mM CaCl2). Incubation was then continued for different 
times in either low glucose KRH alone (controls) or in the presence of various 
secretagogues (SIGMA-Aldrich, Italy). The stimuli used were a secretagogue mixture 
(SM: 16.7 mM glucose, 1 mM isobutylmethylxantine (IBMX), 0.1 pM phorbol 12- 
myristate 13-acetate (PMA), 10 pM forskolin; modified from 396), used to induce 
maximal secretion; glucose, PMA or forskolin given individually; or iono (ionomycin) 
(0.1-10 pM). For the [Ca2+]-free experiments, BAPTA-AM (50 pM) was administered 
to the cells for 45 minutes prior to secretagogues in [Ca2+]-free KRH additioned with 1 
mM EGTA, pH 7.4. In the characterisation of Rin-5 AH cells and sub-clones cells were
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incubated with a mixture of 50 mM KC1 and 27 mM glucose (gluc/KCl), with SM or 
with 100 (iM tolbutamide alone or in the presence of glucose and SM.
Supernatants were collected at the indicated time-points, centrifuged at 2,000 rpm for 2 
min at 4°C to remove any detached cells, and stored at -80°C. Cell monolayers were 
solubilised on ice with lysis buffer containing 50 mM Hepes pH 7.5, 150 mM NaCl, 15 
mM MgCh, 1 mM EGTA, 10% (W/V) glycerol, 1% (W/V) Triton X-100, 0.5 mM 
PMSF, and the protease inhibitor cocktail described for Western blotting. After lysis at 
4°C for 30 minutes the cells were thoroughly homogenised by pushpull through a 26G 
needle and freeze-thawed 3-fold to ensure complete solubilisation of Ins and cellular 
proteins. Cell lysates were eventually centrifuged at 13,000 rpm for 15 min at 4°C and 
the supernatants stored at -80°C.
Ins and CgB assays
Insulin - Ins levels in media and lysates were measured by the rat Insulin ELISA kit 
(Mercodia AB, Uppsala, Sweden) following the manufacturer’s indications. Ins levels 
in cell lysates and media of RIN-5 AH cells and subclones were measured by the Linco 
rat insulin RIA kit (Linco Research, USA), since being the Ins content of these cells 
very low the differences among the samples are little appreciated with the ELISA kit, 
where most samples are in the first part of the standard curve. The RIA kit allows to 
better distinguish little differences in the Ins content. INS1-E cells were also analysed 
by RIA when they had to be compared to RIN-5 AH cells.
The results were expressed as % of released Ins over total Ins content. In each 
experiment, the mean % release values were obtained from triplicate wells. Given 
values ± s.e.m. are averages of three to six experiments.
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Chromogranin B - CgB levels were determined by dot-blot assay 397. Total proteins of 
cell lysates and the entire volume (600 ul) of supernatants from secretion assays were 
diluted in 10% (V/V) methanol, 0.5% (W/V) sodium-deoxycholate, 50 mM Tris pH 7.4, 
and 150 mM NaCl, together with the antiprotease mixture. Samples were then loaded 
onto a 0.22 pm pore size nitrocellulose membrane (Biorad laboratories, Italy) in a dot- 
blot apparatus connected to the vacuum. Protein-loaded membranes were air dried at 
room temperature, then immediately processed as previously described for western blots 
and finally detected with Western Femto Signal (Pierce Biotechnology Inc., Rockford, 
IL, USA). Chemiluminescence images were acquired every 30 seconds in a UVP 
Bioimaging System (UVP, Inc., Upland, Ca, USA) by the dynamic integration mode. 
Samples to be compared were processed in parallel, in order to acquire the images with 
identical settings. Dot intensities were integrated with the LabWorks™ Image 
Acquisition and Analysis software (UVP, Inc., Upland, Ca, USA). Following correction 
for dilution factors, optical densities (OD) were used to calculate the % released CgB 
over total CgB ± s.e.m. Dot blots were incubated with a mixture of two anti-CgB 
antibodies: the rabbit polyclonal anti-CgB PE-11 (working dilution 1:400) and the 
mouse monoclonal anti-CgB CIRO (working dilution 1:1000).
Ca2+ measurements
Ca2+ measurements were performed using two different techniques: spectrofluorometric 
analysis and single-cell imaging.
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Fluorometric analysis — Cells were grown on poly-L-lysine-coated coverslips manually 
cut to fit in a fluorometric cuvette 398. After incubation for 30’ at room temperature with 
the Ca2+ dye Fura-2/AM (Calbiochem, Merck Biosciences, Germany) in KRH (final 
concentration 5 pM) and washing, the slides were positioned at appropriate angles in 
the cuvette by a custom-made adapter. The cuvettes, equipped for medium stirring, were 
placed in a Perkin Elmer LS5 fluorometer. The temperature of the system was set at 
37°C. After basal recording, cells were stimulated for 20 minutes with either the 
previously described SM or 100 pM carbachol (carbamylcholine chloride; SIGMA- 
Aldrich, Italy). The fluorometer measured the two wavelengths of emission of Fura- 
2/AM, i.e. 340 nm and 380 nm, corresponding to free and to bound cytosolic Ca2+, 
respectively. The data were expressed as 340/380 ratio.
Single-cell imaging - The cells were plated on poly-L-lysine-coated 24 mm coverslips 
as previously described and used after two-three days, when they reached the sub­
confluence. Upon incubation in low glucose KRH for 1 hour at 37°C, the cells were 
loaded with 2.5 pM Fura-2/AM in KRH for 30 min and washed. After placing the 
coverslips in a thermostatic chamber on the stage of a Zeiss Axiovert 200 inverted 
microscope, the cells were observed with a 40x objective at resting conditions (KRH) 
and upon stimulation with the previously described SM for 20 min. The fluorescent 
signals of the two wavelengths of Fura-2AM (340 and 380 nm) were monitored (0.2 
frame/sec) and the ratio between them was calculated by the MetaFluor 5.0 software. 
The settings for each set of experiments were constant in order to compare the different 
cell types.
These experiments were carried out in the laboratory of Prof. Rizzuto, University of 
Ferrara, Italy, that kindly provided his equipment, reagents and knowledge.
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ATP detection
Cells were plated in 96 well-optical compatible plates (Coming, Celbio, Italy) two days 
before the experiment and used when they reached sub-confluence. ATP and ADP 
levels in cell lysates and media were revealed by the Apoglow kit (Cambrex Bio 
Science, Italy) according to the manufacturer’s protocol. Upon incubation for 1 hour in 
low glucose KRH, the cells were either stimulated or not with SM and reagents of the 
ATP detection kit were added 3 min after stimulation start, since the production of ATP 
upon stimulation of Ins secretion occurs within the first 4 minutes 140 and then the ATP 
is rapidly consumed for the exocytotic events. The luminescence produced by the 
reaction of ATP with luciferine and oxygen was measured at the Victor3 luminometer, 
and the results were expressed in arbitrary units of luminescence.
Analysis of mitochondria
Mitotracker staining
Cells were plated at low density on poly-L-lysine-coated 24 mm coverslips and used 
two days later. Upon incubation for 1 hour 30 min in low glucose KRH, they were 
loaded for 30 min at 37°C with a suitable concentration (25 nM and 50 nM for INS1-E 
and Q2 cells respectively) of Orange Mitotracker (Molecular Probes, Invitrogen Co., 
USA) diluted in DMEM supplemented with 2.8 mM glucose and 10% FCIII. The 
coverslips were then washed with KRH solution and placed in a thermostatic chamber 
on the stage of the DeltavisionTM wide-field microscopy system; the images were 
acquired with a lOOx objective at a resolution of 1024x1024 pixels. Image
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deconvolutions, tridimentional cell reconstructions and analysis of the tiff files 
generated were performed as previously described.
AWm measurements
The cells were seeded on 24 mm coverslips two-three days before the experiment and 
used when they reached the sub-confluence. Upon incubation for 1 hour 30 min in low 
glucose KRH, the cells were loaded with 10 nM TMRM (tetramethylrhodamine methyl 
ester; Molecular Probes, Invitrogen Co., USA) in low glucose KRH for 30 min at 37°, 
and then placed in the presence of TMRM in a thermostatic chamber on the stage of a 
Zeiss Axiovert 200 inverted microscope. The cells were monitored at resting conditions 
for 2 min and then stimulated for 20 min with the previously described SM. At the end 
of the stimulation was uncoupled with 1 jiM FCCP (carbony 1-cyanide 4- 
(trifluoromethoxy)phenylhydrazone; SIGMA-Aldrich, Italy). A single confocal plan of 
TMRM fluorescence was acquired for each group of cells analysed. Cells were imaged 
(0.1 frame/sec) by the Zeiss LSM 510 confocal system (Carl Zeiss, Jena, Germany) 
with a 40x objective at a resolution of 512x512 pixels. TMRM intensity was quantified 
using the Zeiss LSM and Metamorph 5.0 softwares.
Gene expression analysis
RNA extraction and reverse transcription
The cells were solubilised with Trizol LS Reagent (Invitrogen Co., USA) and the RNA 
was exctracted with chloroform and precipitated with isopropanol according to the
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manufacturer’s protocol. The quality and amount of the recovered RNA was evaluated 
by spectrophotometric measurement (ODj^o and ratio OD^o/OD^so) and by 
electrophoresis on agarose-formaldehyde gel. Equal amounts of RNA from all the 
samples (4 pg) were pretreated with RNase-free DNase (Invitrogen Co., USA) and then 
reverse transcribed by the SuperScriptHI kit (Invitrogen Co., USA) using a provided 
Oligo(dT) mix according to the manufacturer’s protocol; the cDNA obtained was then 
analysed by PCR and electrophoresis.
Qualitative and semi-quantitative PCR analysis
The PCR aimed at the gene expression analysis were performed with the Fast Start Taq 
DNA Polymerase (Roche Applied Science) according to the manufacturer’s protocol 
and adding the provided GC-Rich reagent to templates in order to enhance the 
efficiency of the amplification of genes particularly rich in guanine and cytosine bases. 
The PCR were performed at the suitable annealing temperature and at 35 cycles using 
equal volumes of template.
The semi-quantitative PCR performed to analyse the expression of the markers of ER 
stress and granules were set up in the following way: Gapdh was used as a 
housekeeping gene to normalise the quantification in the different sets of samples. The 
amount of template (10 ng) and enzyme (0.1 pM) GoTaq DNA Polymerase (Promega, 
Italy) were adjusted in order to perform a non-saturating amplification of the cDNA, 
and the number of cycles for each gene was decided after performing three PCR of 
different cycles number, in order to select an amplification condition which was in the 
linear range, before saturation was reached. The amplified products were loaded on 
agarose gel, analysed by electrophoresis and imaged with UVP, Inc. (Upland, Ca, Usa)
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using the same settings in order to compare the different sets of experiments; the 
quantification was performed with the Image Quant software (Molecular Dynamics) and 
the OD obtained for each gene was normalised with that of Gapdh in the same sample.
Primers sequences
The primers sequences were designed either manually or with the 01igo4 software 
(EMBL, Heidelberg) and their specificity was checked by BLAST alignment (NCBI 
search tools). The primers used for the expression analysis and the length of the 
obtained fragments are listed in the table below.
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Gene Forward Prim er (5 ’-3 ’) Reverse prim er (5 ’-3 ’) Fragment
size
Actin GGCATCCTGACCCTGAAGT CGGATGTCAACGTCACACTT 600 bp
GAPDH GCGATCGCGAAACCCTGGACCACCC GATATCGAACTTTATTGATGGTATTCGAG 190 bp
CHOP CCAGCAGAGGTCACAAGCAC CGCACTGACCACTCTGTTTC 125 bp
U C P 2 CGAAATGCCATTGTCAACTG CAAGGGAGGTCGTCTGTCAT 100 bp
ATF 4 AGAATGGCTGGCTATGGATG GCCAATTGGGTTCACTGTCT 250 bp
XBP-1 AAACAGAGTAGCAGCGCAGACTGC GGATCTCTAAAACTAGAGGCTTGGTG 600 bp
BIP GAGTTCTTCAATGGCAAGGA CCAGTCAGATCAAATGTACCC 328 bp
INS I GTCCTCTGGGAGCCCAAGCCTG CAAGGTCTGAAGATCCCCGGCCT 200 bp
INSII TCATCCTCTGGGAGCCCCGC GGTCTGAAGGTCACCGGCCC 200 bp
SNAP 25 CAACGTGCAACAAAGATGCT CAATGGGGGTGACTGACTCT 202 bp
CgA GCCAACAATACCCAATCACC CTTTAGGCCCAGCCTTCTCT 225 bp
CgB AAGAGGAGTCAGTGGCCAGA CTCTGAAGCCCGGTAGTGAG 334 bp
ICA 512 GGGACAGACTTCAGCTCGAC GCCAAAGACAGGTTCTGCTC 220 bp
ERP-57 TCCCATTAGCAAAGGTGGAC CACCACCGAGGCATCTTTAT 200 bp
SYP CTTGCTGCCCATAGTCGC CCTTCAGGCTGCACCAAGT 775 bp
PdX-1 CCTGCGTGCCTGTACATG CCACGCGTGAGCTTTGGT 294 bp
Nkx6.1 ATCTTCTGGCCCGGAGTGAT GCGTGCTTCTTCCTCCACTT 281 bp
Nkx2.2 AGAAAGGTATGGAGGTGACGCC CGCTCACCAAGTCCACTGCT 260 bp
Pax6 CACAGCGGAGTGAATCAGCT CTGTCTCGGATTTCCCAAGCA 344 bp
NeuroD/
CTTGGCCAAGAACTACATCTGG CGACTGGTAGGAGTAGGGGTGTA 238 bp
Beta2
Isll TGATGAAGCAACTCCAGCAG CAGTTGCTGAAAAGCAGGCT 209 bp
119
Analysis of apoptosis
FACS analysis
In order to evaluate the induction of apoptosis upon Tg treatment, control and treated he 
cells were analysed by propidium iodide (PI) staining at the flow cytometry 
(FACSCAN, Becton Dickinson). The cells harvested after detaching with PBS and 
from the medium were centrifuged, washed and then fixed and permeabilised with 
chilled 70% ethanol at -20°C for at least 30 min. The pellets were then washed in hypo- 
osmotic PBS and stained with 1 pg/ml PI (SIGMA-Aldrich, Italy) in the presence of 0.1 
mg/ml RNase. The FACS analysis was performed within 2 hours after the staining.
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